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Abstract
Radiation therapy is a main component of treatment for many lung cancer patients. However,
the respiratory motion can cause inaccuracies in radiation delivery that can lead to treatment
complications. In addition, the radiation-induced damage to healthy tissue limits the
effectiveness of radiation treatment. Motion management methods have been developed to
increase the accuracy of radiation delivery, and functional avoidance treatment planning has
emerged to help reduce the chances of radiation-induced toxicity. In this work, we have
developed biomechanical model-based techniques for tumor motion estimation, as well as
lung functional imaging. The proposed biomechanical model accurately estimates lung and
tumor motion/deformation by mimicking the physiology of respiration, while accounting for
heterogeneous changes in the lung mechanics caused by COPD, a common lung cancer
comorbidity. A biomechanics-based image registration algorithm is developed and is
combined with an air segmentation algorithm to develop a 4DCT-based ventilation imaging
technique, with potential applications in functional avoidance therapies.

Keywords
Four dimensional computed tomography (4DCT), Lung Cancer, Radiation Therapy,
Biomechanical Modeling, Finite Element Modeling, Chronic Obstructive Pulmonary
Disease, Functional Avoidance Planning, Ventilation Imaging, and Deformable Image
Registration
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Summary for Lay Audience
Lung cancer is the leading cause of cancer-related death in Canada. Radiation therapy is a
main component of treatment for many lung cancer patients, in which high-energy beams are
planned to target the tumor cells and destroy them.
Both the lung and the tumor can move and deform during the radiation therapy as the patient
breathes. If not accounted for, the motion of the tumor can considerably reduce the
effectiveness of treatment. An ideal solution is to develop a system that can track the tumor
in real-time and guide the radiation delivery accordingly. This tracking system requires
accurate estimation of the tumor’s location and shape. Currently, four-dimensional computed
tomography (4DCT) scans of the patients are used to plan the radiation delivery. We have
developed a technique for estimating tumor motion/deformation by modeling the breathing
mechanics using 4DCT scans. Our biomechanical model mimics lung physiology and is
driven by the pressure and diaphragm motion present during a breathing cycle. Chronic
obstructive pulmonary disease (COPD), is a progressive lung disease that commonly coexists
with lung cancer and affects the lung mechanics in a heterogeneous manner. By
incorporating these heterogeneous changes in the lung mechanics into our model, we
achieved high accuracies for tumor motion/deformation estimation.
Radiation treatment planning aims at maximizing the tumor dose while minimizing the
healthy lung tissue exposure to radiation. Considering the heterogeneity in the lung function
present in cancer patients (due to COPD and/or smoking), the outcome of radiation therapy
can be improved by planning the radiation beam to deliberately avoid the well-functioning
regions in the lung and instead pass through the already poorly-functioning regions. This
method of planning is called functional avoidance and requires regional information on lung
function that is usually obtained using magnetic resonance (MR) or nuclear medicine
imaging. We have developed a 4DCT-based technique for imaging the regional ventilation,
as a surrogate for lung function. 4DCT is a cost effective and accessible alternative to the
current modalities. Our ventilation imaging method utilizes our accurate lung biomechanical
model to find the regional change in the air volume, i.e. ventilation. Results show good
agreement with MR-based functional images.
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Chapter 1
« Introduction»

1

Lung cancer remains the leading cause of cancer-related deaths among men and women
in Canada (1). Effectiveness of radiation therapy, as a main component of lung cancer
treatment in many patients, may be reduced by uncertainties caused by respiratory motion
and damage to healthy tissues. Respiratory motion compensation methods have emerged
as potential solution for the former (2,3), and functional avoidance techniques have been
developed to alleviate the latter (4,5). In this thesis, we describe biomechanical modelbased techniques for motion estimation and functional imaging to help improving the
effectiveness of radiation therapy.

1.1
1.1.1

« Lung Cancer »
Statistics

Cancer is the leading cause of death in Canada, with approximately 1 in 2 men and 1 in
2.2 women expected to develop cancer in their lifetime (1). Lung and bronchus (referred
to as lung for brevity), colorectal, breast, and prostate cancers are the most commonly
diagnosed cancer types in Canada. They are responsible for about 50% of all cancer
deaths in 2017 (Figure 1-1) (6). As shown in Figure 1-1, with incidence rates higher than
all other cancer types, lung cancer kills more people than colorectal, breast, and prostate
cancers combined (1). The World Health Organization estimates that lung cancer is the
cause of 1.59 million deaths globally per year, with 71% of them caused by smoking (7).
The 5-year survival rate of lung cancer is only 19% (Figure 1-1).

2

Figure 1-1. Lung cancer annual incidence, annual deaths, and 5-yeas survival rate
statistics (1).
This rate is dependent on the type of the lung cancer (small cell lung cancer (SCLC) or
non-small cell lung cancer (NSCLC)) and the stage at which it is detected (1). For
example, estimates of five-year survival rates range from 1% to 10% across the substages
of stage IV, and from 68% to 92% for the substages of stage I. Five-year survival
estimates are lower for SCLC: 2% for stage IV and 31% for stage I (1). NSCLC accounts
for more than 80% of lung cancer cases and has three major histologic subtypes that are
categorized by the cell type from which the disease originates (8). 1) Adenocarcinoma
starts in glandular cells, is usually located along the outer edges of the lung and is more
common among women and non-smokers. 2) Squamous cell (or epidermoid) carcinoma
starts from squamous cells, usually occurs in one of the main airways or in the central
part of the lung and is strongly associated with smoking. 3) Large cell lung cancer is
distinguished from SCLC by the large cancer cells size, and is often found in the
periphery, and are more commonly diagnosed in men (8). Figure 1-2 shows the incidence
of different lung cancer types (8,9).

3

Figure 1-2. Relative incidence of different lung cancer types (9).

1.1.2

Comorbidities: Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease (COPD), is a progressive lung disease that fatally
deteriorates the lung function over time. COPD is the 4th most common cause of
hospitalization among men and the 6th most common cause of hospitalization among
women in Canada. COPD is the only chronic disease with increasing mortality and is
estimated that it will be the 3rd leading cause of death worldwide by 2020 (10,11).
The damage to the lungs in COPD is caused by exogeneous (caused by smoking) or
endogenous

oxidative

stress,

protease

activity,

autoantibody

expression,

and

inflammatory cytokine release. These will cause several pulmonary manifestations,
including alveoli wall damage (emphysema) and small airways disease (SAD), which
will in turn cause air trapping and lung hyperinflation (12).
Emphysema is pathologically described as permanent destruction of the alveoli walls,
resulting in abnormal permanent enlargement of the air spaces distal to the terminal
bronchioles (Figure 1-3). The destruction of the alveoli walls results in a decrease in the
surface area available for exchange of O2 and CO2 to and from the capillaries (Figure
1-3) (12). As shown in Figure 1-3 emphysema can be detected on computed tomography
(CT) scans taken at full inspiration. The extent of emphysema can also be quantified
using information derived from CT scan (13).
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(a)

(b)

Figure 1-3. Emphysema. (a) Schematic comparing the alveoli structure in healthy and
emphysematous tissues. The breakdown of the airway walls enlarges the alveoli and
decreases the effective surface area for O2 and CO2 exchange. Reproduced with
permission. Copyright 2019, Mayo Foundation for Medical Education and Research. (b)
Regions affected by emphysema can be detected on CT scans as low attenuation areas
(sample regions enclosed in red ellipses).
The patterns of emphysema observed in COPD are classified to centrilobular (airways
destruction observed around the terminal bronchioles) and panlobular or panacinar
(homogeneous airways destruction) (12,14).
The airways with internal diameter smaller than 2 mm that extend from the 8th generation
airways to the alveoli are classified as “small airways” (Figure 1-4). The cross-sectional
surface area of the small airways is far greater than that of the large airways; however,
they are responsible for only about 10% of the total airways’ resistance. Therefore,
conventional pulmonary function tests may fail to detect abnormalities even when
extensive disease is present in the small airways. In COPD, SAD mostly involves
remodeling of the small airways, along with an increase in airways smooth muscle,
destruction of alveolar attachments, and airway wall fibrosis (12,15). Assessment of SAD
is challenging. A number of invasive and non-invasive methods have been reported for
diagnosis and assessment of SAD. The invasive methods are based on histological
analysis on transbronchial biopsy samples or surgically resected specimens(16).
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Figure 1-4. The classification of airways to large and small airways based on branching
and diameter. The acinar zone is where the gas exchange happens, and it starts from
terminal bronchioles. Reproduced with permission (15). Copyright 2012, Taylor &
Francis.
The non-invasive methods are based on imaging or physiological assessments (15).
Imaging is an attractive option for assessment of SAD, and COPD in general, especially
in the case of lung cancer patients where imaging of the lungs is part of the routine care
in most centers. Standard CT, high resolution CT, and hyperpolarized gas magnetic
resonance imaging (MRI) are widely used for diagnosis, and assessment of disease
progression and treatment response (16). Single-proton emission computed tomography
(SPECT) and proton emission tomography (PET) can also be used for characterization of
COPD, as they provide more insight into ventilation-perfusion relationships in the
peripheral lung regions (17,18).

1.1.3

Lung Cancer and COPD

More than 65% of lung cancer patients also suffer from COPD (11,19). Beside the fact
that smoking has proven to be a cause for both COPD and lung cancer, there is increasing
evidence that links these two diseases beyond the one common etiology. Lung cancer is
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up to 5 times more likely to affect smokers with COPD than smokers with normal lung
function (20). A 2- to 6-fold higher risk of lung cancer in COPD patients have been
reported to be regardless of smoking habits (21,22). Common mechanisms in COPD and
lung cancer, such as premature aging in the lungs, common pathogenic factors, or genetic
predispositions to either disease was explored as possible explanations for the high
coexistence of lung cancer and COPD (21). COPD is known as an independent risk factor
for lung cancer, respiratory-related complications, and postoperative recurrence of
NSCLC (19). A number of previous studies have reported that coexisting COPD leads to
poor prognosis for lung cancer (11,19).

1.2

« Lung Cancer Treatment »

The treatment strategy for lung cancer depends on factors such as the subtype and stage
of the malignancy, histology, patient’s age, comorbidities, and patient’s preference.
Comprehensive guidelines for diagnosis, staging, risk assessment, and treatment have
been developed and are used in clinical practice for optimal outcome (23,24). Stage
grouping of the malignant tumors according to the TNM guide is based on the extent of
the primary tumor (denoted by T), regional lymph node metastasis (N), and distant
metastasis (M) (Table 1-1). Treatment can be either or a combination of surgery,
immunotherapy, chemotherapy, targeted therapy, and radiation therapy. Some treatment
strategies are preferred over the others for different stages. A summary of recommended
treatment strategies based on stage grouping and guidelines for diagnosis and pathology
can be found in (23,24).

1.2.1

External Beam Radiation Therapy

External beam radiation therapy (EBRT) with curative intent is a main component in the
current standard of care as primary or adjuvant treatment for early stage NSCLC and
unresectable locally advanced NSCLC (23,25). In addition, radiation therapy is used for
palliative purposes for alleviating bronchial obstruction or to relieve symptoms such as
pain, cough, or bleeding (8,23,26).
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In EBRT, high-energy particles or waves such as x-rays, protons, gamma rays, or
electron beams are planned to target the tumor cells and damage their DNA. Radiationinduced damage to the DNA kills malignant cells or impairs their proliferation (8).

Table 1-1 Summary of lung cancer staging guideline. Adapted from (99).
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The amount of energy per unit mass that is deposited (or planned to be delivered) is
measured as “dose” of radiation in Gray (Gy) (27). Radiation therapy generally ranges
from static beams to multiple rotating beams all exploiting the concept of superposition
to deposit the prescribed doses in the tumor volume while sparing surrounding normal
tissue within the human body. The primary goal of radiotherapy is to maximize tumor
control probability (TCP) while minimizing normal tissue complication probability
(NTCP) (28). Therefore, the mitigation of high dose to organs at risk (OARs) and healthy
tissue is crucial to the success of radiotherapy and avoiding negative radiation-related
side effects. A treatment planning system is used for radiotherapy treatment planning,
optimization and 3-dimensional dose calculation (29). For radiotherapy planning, a total
prescribed dose is typically broken down into multiple treatment sessions or treatment
fractions. Modern radiotherapy employs the use of 4-dimensional computed tomography
(4DCT) imaging of the patient's body to target the tumor volume and guide the highenergy radiation beams (29). Within the CT dataset, a physician segments the gross
tumor volume (GTV), based on his or her own clinical experiences, as well as clinical
guidelines on disease specific characteristics such as pattern specific progression and
staging. Two additional margins are added on top of the GTV to account for different
types of uncertainty in radiation delivery. The first supplementary margin is added to
create the clinical target volume (CTV), which accounts for uncertainty related to
microscopic spread of disease that is not visible to the physician in the CT dataset. A
second margin is subsequently added on top of the CTV to account for uncertainties that
arise from both inter- and intra-fractional motion, resulting in the internal target volume
(ITV). The planning target volume (PTV) encompasses the ITV and is larger by margins
to account for set-up variations, geometric uncertainties, and machine tolerances (29, 33).
Subsequently, OARs and critical structures are also segmented. OAR segmentations are
necessary, as they serve as dose limiting structures during treatment plan optimization.
They need to be spared for successful treatment with minimal toxicities to ensure suitable
long-term quality of life for patients.
The radiation dose distribution and hence TCP and NTCP depend on the radiation
therapy technology used. Modern radiation therapy techniques such as stereotactic body
radiation therapy (SBRT) have been developed to provide better control over dose
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distribution, compared to conventional techniques such as three-dimensional conformal
radiation therapy (3D-CRT) (30). 3D-CRT uses multiple co-planar fields to maximize
tumor dose coverage and minimize normal tissue exposure. In 3D-CRT, the prescribed
dose is usually delivered over the course of four to eight weeks, in 20 to 40 daily
fractions. The basic idea of CRT is based on tailoring the apertures of the beam to the
shape of the PTV in 3D, while masking nearby OARs (Error! Reference source not
found.) (31). A more complex beam configuration might be required when the PTV is
close to an OAR, and to achieve an acceptable dose distribution a higher number of
beams are often used. However, conventional 3D-CRT may fail in cases of concaveshaped target volumes and moving targets. In addition, in 3D-CRT, beam margins by
which the tumor is expanded to account for tumor and organ motion, and the planning
and setup inaccuracies are large (on the order of centimeters) (31).

Figure 1-5. Schematic of the 3D conformal radiation therapy.
Reproduced with permission (31). Copyright 2008, SNMMI.
SBRT refers to an emerging radiotherapy procedure that has been reported to be highly
effective in controlling early stage primary and oligometastatic cancers at locations
throughout the abdominopelvic and thoracic cavities, and at spinal and paraspinal sites. In
SBRT, the PTV contains a much smaller margin together with the target tumor,
compared to when 3D-CRT is used. The major feature that separates SBRT from
conventional radiation treatment is the possibility of delivering large doses in a few
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fractions, which results in a high biologically effective dose (32,33). Conformation of the
ablative dose to the target shape and rapid decrease in the dose outside the target is
critical for minimizing the normal tissue toxicity and hence the safe delivery of the high
dose. Therefore, effective use of SBRT requires a high level of confidence in the
accuracy of the radiation delivery process. To achieve this accuracy, SBRT is
characterized by target localization using imaging (e.g. 4DCT, MR), patient
immobilization,

sophisticated

planning

software,

accurate

treatment

delivery

technologies, and the ability to produce a steep dose gradient outside the target volume
(33). In addition to these major features, there are other characteristics that distinguish
SBRT from conventional radiation therapy (30) (Table 1-2). These include a general
increase in the number of beams used for treatment, the frequent use of noncoplanar
beam arrangements, and the use of inhomogeneous dose distributions techniques such as

Table 1-2 Comparison of some characteristics of 3D-CRT and SBRT. Reproduced with
permission (30). Copyright 2010, John Wiley and Sons.
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intensity modulated radiation therapy (IMRT) and volumetric modulated arc therapy
(VMAT) (30). IMRT utilizes forward or inverse radiation treatment planning to
determine and deliver the necessary dose distribution through the use of multileaf
collimators (Figure 1-6) (34). VMAT is a more advanced type of IMRT that decreases
the delivery time by applying the dose in a single gantry arc and improves the dose
conformality by using the full 360° range of gantry rotation (35).
Accurate delivery of ablative radiation is challenging for extracranial lesions due to interand intra-fraction tumor and organs motion. Respiration-induced motions of the target
and OAR renders the treatment delivery even more challenging for lung tumors (33).
This motion can cause inaccuracies and uncertainties in radiation therapy, and artifacts in
imaging of the thoracic tumors resulting in higher probabilities of treatment
complications such as irradiating normal tissue (increase in NTCP) and undesirable dose
distribution in target tumor (decline in TCP) (36,37). Therefore, motion compensation
methods are highly essential for safe delivery of large fractions of radiation therapy.
Section 1.3 describes current motion management methods as well as an overview of the
real-time tumor tracking workflow previously proposed by our group.
Current methods of radiation therapy treatment planning assume a homogeneous

Figure 1-6. 3D CRT vs. IMRT. (a) in 3D CRT, dose conformality is limited to the
open/close aperture configuration, while (b) IMRT, offers higher dose conformality
resulting in smaller margins and higher potential for less toxicity to OAR. Reproduced
with permission (100). Copyright 2006, Springer-Verlag Berlin Heidelberg.
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distribution of lung function (38). However, as mentioned in section 1.1.2, pulmonary
abnormalities such as COPD and asthma commonly coexist with lung cancer, leading to
pulmonary function heterogeneity. To limit high radiation dose delivery to healthy tissue,
functional avoidance treatment planning has been proposed (5,38,39). This method
preferentially spares the functional lung tissue from radiation dose during treatment
planning. Section 1.4 provides more information on functional avoidance planning, the
current functional imaging methods and an overview of our proposed ventilation imaging
technique that can be used for functional avoidance planning.

1.3

«Motion Management Methods»

Accounting for inter- and intra-fraction motions of the target and OAR are critical for the
safe delivery of radiation dose. The location of the target and OAR may be different from
their location at the radiation treatment planning and simulation. Accurate positioning of
the target lesion in the isocenter of the radiation therapy machine requires that the body
geometry during the treatment session is almost identical to the body geometry during
treatment planning simulation. In addition, it is required to suppress or, if possible,
eliminate the voluntary motion of the body during treatment (33). Henrik Blomgren and
Ingmar Lax designed a body frame to minimize the inter-fraction motion. This body
frame allows comfortable repositioning of the patient’s body relative to the frame. The
frame is equipped with fiducial markers that determine the coordinates system relative to
the frame geometry, and hence enable an accurate localization of the body relative to the
simulator and the treatment accelerator (40). Vacuum systems have also been developed
for enforcing patient immobilization and are used in some centers (33). Although the
body frames or the vacuum systems largely resolves the inter-fraction motion issues, the
intra-fraction motion and deformation of the lungs and the tumor caused by respiration
can significantly increase the uncertainties in radiation treatment and compromise its
accuracy and effectiveness. To account for respiratory motion, several motion
compensation methods have been proposed.
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1.3.1

Motion Encompassing

In motion encompassing treatment planning, the PTV includes the target volume at endexhalation phase, or GTV (obtained from treatment planning 4DCT), along with a large
margin that encompasses the entire path of the tumor motion/deformation (Figure 1-7)
(41). In this method, the PTV which is irradiated with high dose radiation is larger than

Figure 1-7. Motion encompassing. PTV includes the entire path of tumor’s motion from
expiration to inspiration, along with extra safety margins.
the GTV and may include a significant volume of the healthy lung tissue (42). This may
lead to higher chances of radiation-induced toxicities and higher NTCP. The motion
encompassing method can only be used when the amplitude of the target motion is less
than 5mm, because otherwise the potential damage extent to the healthy tissue is deemed
unacceptable (3). Several studies have investigated the amplitude of the motion of the
tumor in different directions (43–46), and a few others studied the range of motion during
diaphragm contraction (47,48). According to Table 1-3, on average the range of lung
tumor motion/deformation is larger than 5 mm (3). Therefore, other motion compensation
methods with better accuracy for sparing of normal tissue are required.

1.3.2

Gated Methods

Gated radiation therapy methods for lung cancer are developed based on the assumption
that during the respiratory cycle there is a particular span of time where the amplitude of
the respiratory motion is small (Figure 1-8). To decrease the treatment field margins (for
PTV), in gated procedures, the radiation beam is only applied during the portion of the
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breathing cycle with the smallest target motion (the gating phase). The gating phase of
the breathing cycle has to be identified and verified positionally for each patient and the
beam has to be switched on and off accordingly during the treatment session (49). Realtime information on the breathing cycle is required for this method to enable
synchronizing the on and off turning of the beam. Breathing monitoring devices for
Table 1-3 Respiratory-induced motion of the lung tumor and diaphragm in different
directions. Reproduced with permission (3). Copyright 2006, John Wiley and Sons.

respiratory gating most often rely on surrogates for the actual motion of the target, such
as an external optical skin marker or a pressure sensor.
The variability and irregularity of breathing patterns results in a lack of predictability of
breathing motion. Therefore, as shown by Korreman et al. (50), image guidance is of
utmost importance for respiratory gated treatments. The correspondence between the
breathing motion recorded from the external surrogate and the breathing motion of the
target can change, not only from fraction to fraction but also within each treatment
fraction. Therefore, when external surrogates are used for motion monitoring, the
correspondence between the motion of the surrogate and target motion needs to be
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updated and verified regularly. Otherwise, the target may not receive the effective dose
while the normal tissue receives toxic radiation (49).
Several imaging techniques can be used during radiation therapy and for treatment
planning of gated procedures. During treatment, radiographic and fluoroscopic kV
imaging are now standard for new machines. Imaging equipment can either be mounted

Figure 1-8. Gated Radiation therapy. The motion of the tumor is smallest at certain
windows of time (gates) during respiration. The radiation is applied only during these
gates. Reproduced with permission (49). Copyright 2015, British Journal of Radiology.
on the linear accelerator gantry, which is mostly orthogonal to the treatment beam, or can
be independently mounted on the ceiling or floor of the treatment room, orthogonally.
Two orthogonal imaging setups can be combined to provide semi-3D information.
Imaging units mounted on the gantry can also be used for cone-beam CT imaging.
Because the acquisition time of cone-beam CT (CBCT) is long compared to the breathing
cycle, the target position image may appear blurred in the image. 4D CBCT has also been
developed that acquires phase-resolved CBCT(49,51).
Respiratory gated methods do not completely abolish the need for margins when
assigning the PTV. Breathing motion patterns are not stable (especially among lung
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cancer patients), and hence not completely reproducible in the spatial domain. If not
accounted for, irregularities in the breathing cycle can render the gated procedures
unreliable. Therefore, treatment margins are required to account for the uncertainties
caused by the residual motion. The uncertainties (and hence the margins) can be reduced
by combining the gated procedures with motion limiting methods. This increases the
chance of delivering the dose to the target as prescribed by the treatment plan (33,52).
Although the modern gated methods can improve the confidence in the accuracy required
for an effective SBRT, they come with shortcomings. The gated sessions inevitably take
longer and this increase in the treatment time can cause inconvenience for the patient that
can lead to body dislocation relative to the treatment frame, and hence a decrease in the
accuracy of treatment delivery. In addition, longer treatment times can have potential
radiobiological consequences caused by the decreased average dose ratio during
treatment (33).

1.3.3

Motion Limiting Methods

Motion limiting methods aim at controlling the respiratory motion amplitude by limiting
the breathing volume. Abdominal compression devices can be used along with the body
frames during SBRT to decrease the respiration-induced tumor motion and hence the
treatment margins. These devices, however, can cause discomfort or even anxiety for
some patients, that may lead to an increased variability in tumor motion. In addition, the
abdominal compression does not eliminate the tumor motion, and this method is not
practical for obese patients (53).
Breath-hold techniques attempt to eliminate respiratory motion either voluntarily or by
using occlusion valves. The holding of the breath allows for a temporary immobilization
of the target tumor when the radiation is planned to be applied. Figure 1-9 illustrates
typical respiratory motion amplitude variation as a function of time where this motion
limiting method is utilized. Patients must be trained on the required breathing maneuver
for both treatment planning CT and radiation therapy session. The patients are required to
hold their breath for 10-20 seconds in each iteration. While relatively effective for target
immobilization, breath-hold techniques are not very commonly used because most lung
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cancer patients have poor pulmonary function and cannot undergo breath-hold procedures
(54).

Figure 1-9. Breath-hold methods. The respiratory motion amplitude decreases during the

breath-hold span. The radiation is applied during this span to reduce uncertainties caused
by tumor motion. Reproduced with permission (49). Copyright 2015, British Journal of
Radiology.

1.3.4

Real-time Tracking Methods

Real-time tumor tracking has been proposed as an alternative motion management
technique in which the radiation beam dynamically follows the target throughout the
treatment. A real-time tumor tracking system ideally follows the motion and deformation
of the tumor during the entire respiratory cycle, allowing a continuous radiation
treatment. There are certain requirements that need to be met for achieving a radiation
therapy system with real-time tracking as the motion management technique, including
(but not limited to): 1) an accurate estimation of the tumor location and geometry in realtime, 2) in advance prediction of the tumor motion/deformation to account for the delays,
3) an adaptive radiation dose planning system, and 4) a beam alignment system (55,56).
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Although imaging techniques are available for use during treatment, for high precision
tumor tracking purposes in real-time, markers implanted in the tumor have been proposed
to increase visibility. This technique has been developed by SynchronyTM Respiratory
Tracking system (Accuray, Sunnyvale, CA). In this system, gold fiducials are implanted
inside the tumor and their motion is monitored by a pair of orthogonal X-ray images. In
addition to the image data, a correlation model used as a location predictor is developed
with an optical monitoring system tracking light emitting markers placed on a vest worn
by the patient. The correlation model compensates for the time delay between data
acquisition and the repositioning of the accelerator. The accelerator is robotically
controlled and allows for non-isocentric beam delivery within a solid angle of over 2π.
The position of the external markers is continuously monitored while the X-ray imaging
of the internal fiducials is performed every 3–5 beams (a flexible parameter). Apart from
accuracy, another major advantage of this method is that the patient breathes freely
during the treatment (57). Tracking the tumor without the need for simultaneous imaging
by implantation of radiofrequency beacons has also been reported, e.g. using the Calypso
system (58). Similar to other tracking systems that are based on implanted fiducials, with
these tracking systems, the translational movement of the tumor can be captured and
compensated for, while the rotation and deformation is not accounted for. As a result,
treatment margins of up to 5 mm may be required depending on the case (33,59). Recent
studies indicate that, during respiration, the size of the target tumor can vary by up to 62%
(60). As such, an effective tumor tracking method should be able to estimate the tumor
deformations as well as translation and deformation. In addition, marker implantation is an

invasive procedure and can be associated with side effects. Risks of pneumothorax for
percutaneous implantation is reported to be as high as 30%, with 10% of the cases
requiring intervention (61,62). To avoid marker implantation, an improved tracking
method, X-sight Lung (Accuracy, Sunnyvale, CA) has been developed that can
dynamically track tumor motion based on the radiograph images for certain lung cases (in
some centers, about 30% of patients). Concurrent X-ray imaging and radiation therapy,
however, has raised some concerns about the additional imaging dose (33).
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1.3.5

Tumor Tracking Workflow

A real-time tumor tracking workflow has been previously proposed by our group (63).
This tumor tracking scheme will not require simultaneous imaging during the treatment,
can also estimate motion and deformation of the tumor, and will only use external
markers. In addition, this method is potentially less sensitive to irregularities in the
breathing pattern. An overview of this method is shown in Figure 1-10. During the pretreatment step, an optical tracking system is incorporated into the treatment planning
4DCT acquisition. A tumor motion and deformation estimation algorithm based on an
accurate patient-specific biomechanical model of the lung is developed using the
treatment planning 4DCT data. The chest surface motion data is acquired simultaneously
with the treatment planning 4DCT using optical tracking of the external markers. The
chest surface motion data can be correlated to the tumor motion/deformation obtained
from the finite element (FE) model.
The information from chest motion data is considered as input parameters while the
parameters of the biomechanical model (in a compact form) will be used as the output for
training a predictive model (e.g. an artificial neural network). After training the predictive
model, a relationship is established between the chest surface motion data and the
parameters of the FE model that directly provides the tumor motion/deformation. For
more detailed information on the proposed real-time tracking workflow, see (63).
The accuracy of the biomechanical model used in this method is critical to the successful
development of the real-time tracking. The second chapter of this thesis explains
development of an accurate biomechanical model for tumor motion and deformation
estimation.
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Figure 1-10. The biomechanics-based real-time tumor tracking workflow.

1.3.6

Biomechanical
estimation

model-based

tumor

motion/deformation

Lung motion/deformation estimation using information from 4DCT scans has been
widely studied for different applications including tumor motion tracking. Although
intensity-based deformable image registration (DIR) methods have been employed to find
the motion/deformation fields of the lungs and the tumor for dose calculation and
treatment planning purposes, their application in real-time tumor tracking is limited to a
few studies (56,64–66). In addition, intensity-based DIR methods are solely based on
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4DCT image data, and they do not take into account the physical properties or
physiological mechanisms involved in breathing. Therefore, they are prone to errors
associated with non-uniqueness of the resulting displacement field, and registration errors
in areas with low image contrast. Handling the sliding motion of the lungs can also be
challenging for motion estimation using intensity-based DIR methods. Biomechanical
models can be adapted to address these limitations; they are widely used alone or in
combination with intensity-based methods. In contrast to intensity-based DIR,
biomechanics-based computational models encompass certain aspects of breathing
dynamics rendering this approach more robust and realistic. Patient-specific lung
biomechanical models that use the thoracic image data to extract the lung’s geometry and
boundary conditions have previously been proposed. Several studies investigated the
effects of model parameters, including tissue mechanical properties (67–69), and
boundary conditions (70) on modeling accuracy. Recently, hybrid hierarchical
approaches have been proposed, in which finite element (FE)-based models are used in
conjunction with intensity-based DIR methods to predict deformation field of the lung in
a respiratory cycle, and to register lung CT image pairs. For example, Han L. et al.,
proposed a hybrid biomechanical model-based DIR for lung peak CT pairs, and showed
that the resulting deformation field can more realistically describe the underlying
physiology to improve the registration accuracy compared to the intensity-based DIR
algorithm (71).
In chapter 2, we describe a heterogeneous biomechanical model of the lung for accurate
estimation of the tumor motion and deformation. This biomechanical model takes into
account the heterogeneity in the mechanical behavior of the lung tissue that is caused by
co-existing COPD phenotypes.

1.4

«Functional Avoidance Treatment Planning»

As mentioned in section 1.2.1, EBRT is the main method of treatment for many lung
cancer patients. However, EBRT is associated with increased risk of radiation-induced
toxicities such as radiation pneumonitis or radiation fibrosis. Radiation pneumonitis with
clinical symptoms occurs in 30-40% of lung cancer patients after receiving concurrent
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chemoradiotherapy and can have an adverse impact on their quality of life. This adverse
effect sometimes results in oxygen dependence and is fatal in severe cases (25).
Current radiation therapy treatment planning methods used in many centers assume that
the lung function is homogeneous, and do not take into account regional differences in
pulmonary function. Therefore, the goal in treatment planning is to minimize the
radiation dose to the total lung volume. However, as mentioned in section 1.1.3, many
lung cancer patients suffer from comorbidities such as COPD, which affect the regional
distribution of lung function. Functional avoidance-based treatment planning has
emerged as a new treatment planning approach, aiming to overcome the limitations
caused by the assumption of homogeneous function (25). Ideally, the radiation therapy
dose should be planned based on minimizing the radiation dose to the well-functioning
volumes of the lung while favoring radiation deposition in the lower functioning
volumes.
Regional information on lung function is a requirement for functional avoidance
planning. Over the last decade, functional imaging maps have been investigated for lung
cancer treatment planning. Positron emission tomography (PET) and single-photon
emission computed tomography (SPECT) scans can be used to obtain functional
information in terms of ventilation and perfusion (72,73). Some researchers have used
PET or SPECT for functional avoidance planning and assessment of the radiation
treatment response (39,74). Nuclear medicine imaging approaches have a relatively low
resolution compared to other imaging modalities. Hyperpolarized 3He MR imaging can
provide information on regional ventilation, and hyperpolarized
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Xe MRI can be used

to obtain information on ventilation, perfusion, or gas exchange (75–77). Although
hyperpolarized gas MRI has enough temporal resolution for ventilation imaging, it is
relatively costly and require tracer gases and additional equipment. Xe-enhanced CT can
be used to provide direct assessment of ventilation distribution (78). Xe (Xenon) gas is
also relatively costly and requires associated hardware to control the delivery. In addition,
this method is limited to axial coverage of about 12-15cm, which may not be sufficient
for thoracic imaging. Using any of the abovementioned modalities for a functional
imaging would also require an extra step of multi-modal image registration with the
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radiation therapy treatment planning CT scans that may introduce errors in lung function
mapping.
4DCT-based ventilation imaging (CTVI) has recently emerged as a cost-effective and
accessible alternative for functional avoidance planning. The CTVI can be considered as
“free information” for functional avoidance planning because 4DCT scans are part of the
routine care for lung cancer patients in many centers. Therefore, acquiring CTVI only
involves additional computational steps, e.g. image processing and analysis.
CTVI-based functional avoidance planning is currently investigated in a number of
clinical trials (79–81). Attempts have been made to validate different CTVI techniques
against a wide range of clinical and experimental modalities for ventilation imaging,
including 99mTc-labelled diethylenetriamine pentaacetate (DTPA) V-SPECT (82), 68Ga
(Galligas) PET (83), 3He MRI (84), 129Xe MRI (85), 81m-Kr (86) and Technegas VSPECT (87).

1.5

«4DCT Ventilation Imaging Methods»

Different approaches have been proposed for CTVI where most of them rely on a
deformable image registration (DIR) algorithm, combined with a ventilation metric.
Some groups used off-the-shelf DIR algorithms while others utilized in-house DIR
methods. The accuracy of the DIR algorithm is critical to the accuracy of the generated
CTVI, however, there has not been a consensus on which algorithm should be used. For a
comprehensive review on different DIR algorithms that have been used for CTVI, see
(88). As for the ventilation metric, current CTVI methods are generally classified as
either Hounsfield units (HU)-based or Jacobian-based algorithms. A few studies have
investigated the combination of the two (88). In the HU-based approaches, the change in
the amount of air in the voxels is considered the surrogate for ventilation. Simon et al.
proposed a relationship between manually registered CT values in Hounsfield units (HU),
HUinhale and HUexhale, and the regional volume change. They assume that the fraction of
air in a CT region is given by:
𝐹𝑎𝑖𝑟 = −

𝐻𝑈
,
1000

(1)
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where 𝐻𝑈 is the image intensity of each voxel (89). The fractional change in air content
within a specified volume is then given by:
∆𝑉
(𝐹2 − 𝐹1 )
=
,
𝑉𝑒𝑥
𝐹1 (1 − 𝐹2 )

(2)

where ∆𝑉 is the local volume change due to inspiration, 𝑉𝑒𝑥 is the volume of air within
the exhale CT volume of interest, 𝐹1 is the fraction of air in the exhale CT volume of
interest and 𝐹2 is the corresponding fraction of air in the inhale CT volume of interest. If
we consider the initial exhale volume as a discretized CT voxel, and assume that a threedimensional vector transformation exists to map the set of inhale lung CT voxels into the
exhale image domain, one can derive the following expression for local ventilation in
terms of registered CT numbers corresponding to inhalation and exhalation breathing
states:
𝑉𝑂𝐼
̅𝑖𝑛ℎ𝑎𝑙𝑒
∆𝑉
(𝐻
− 𝐻𝑈𝑒𝑥ℎ𝑎𝑙𝑒 )
= 1000
,
𝑉𝑂𝐼
̅𝑖𝑛ℎ𝑎𝑙𝑒
𝑉𝑒𝑥
𝐻𝑈𝑒𝑥ℎ𝑎𝑙𝑒 (1000 + 𝐻
)

(3)

𝑉𝑂𝐼
̅𝑖𝑛ℎ𝑎𝑙𝑒
where 𝐻
is the average of all the HU corresponding to the set of inhale voxels that

map into the exhale voxel under consideration (90).
Concerns due to physiological violation of the ventilation model given by this equation,
as well as uncertainty resulting from image noise, data acquisition and image
reconstruction artifacts have led others to investigate alternative methods for quantifying
lung function that are independent of the image CT values. Regional volume can be
measured using the Jacobian of the DIR deformation field, Φ (𝑥⃗), alone (91,92). The
Jacobian is defined as the determinant:
𝜕Φ1 (𝑥⃗)
𝜕Φ1 (𝑥⃗)
𝜕Φ1 (𝑥⃗)
𝜕𝑥1
𝜕𝑥2
𝜕𝑥3
𝜕Φ2 (𝑥⃗)
𝜕Φ2 (𝑥⃗)
𝜕Φ2 (𝑥⃗)
1+
𝜕𝑥1
𝜕𝑥2
𝜕𝑥3
𝜕Φ3 (𝑥⃗)
𝜕Φ3 (𝑥⃗)
𝜕Φ3 (𝑥⃗)
1+
𝜕𝑥1
𝜕𝑥2
𝜕𝑥3 ]

1+
𝐽Φ (𝑥⃗) = det
[

25

which calculates the differential expansion (or contraction) at position 𝑥⃗ in the image.
Consider 𝐵𝑥⃗ as a small box around 𝑥⃗ in the exhale image such that Φ (𝐵𝑥⃗ ) is the
corresponding deformed box in the inhale image. The Jacobian determinant of the
deformation Φ (𝑥⃗) at 𝑥⃗ is
𝐽Φ (𝑥⃗) =

𝑣𝑜𝑙(Φ(𝐵𝑥⃗ ))
,
𝑣𝑜𝑙(𝐵𝑥⃗ )

(4)

where 𝑣𝑜𝑙(𝐵𝑥⃗ ) is the volume of the small box centered at 𝑥⃗ and 𝑣𝑜𝑙(Φ (𝐵𝑥⃗ )) is the
volume of the corresponding deformed box. Note that the fractional change in volume
equals the Jacobian determinant of the deformation field at that location. The Jacobian
calculation is independent of the CT values and only depends on the DIR transformation
Φ.
In Chapter 3 we describe our proposed CTVI method that combines a biomechanical
model-based DIR with an accurate air segmentation algorithm. The proposed CTVI
method has qualitatively and quantitatively been compared against the patients’
hyperpolarized 3He MR.
Next sections (1.6 to 1.9) present the theoretical background required for developing the
proposed

methods

for

tumor

motion/deformation

estimation

using the

lung

biomechanical model, and the proposed 4DCT ventilation imaging technique.

1.6

«Image Segmentation»

Image segmentation is defined as partitioning a two-dimensional (2D) or 3D image into
multiple classes. Each class is called a segment and includes voxels that share a property,
hence belong to that class. Image segmentation has various applications in the field of
computer vision, including object recognition, image database look-up, or image
compression. In medical image analysis, image segmentation is usually used to outline an
object or organ of interest manually or automatically. For example, before a tumor is
analyzed in a CT image, it must be detected and isolated from the rest of the image. This
task is performed using image segmentation. Segmentation of medical images also allows
comparison of object/organ of interest between different datasets or modalities and
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monitoring changes in the object/organ of interest (e.g. in treatment response
assessment). It also enables extracting useful quantitative information from images.

1.6.1

Region Growing Algorithm

Region growing is an iterative algorithm used for image segmentation that has a similar
concept to clustering algorithms such as k-means clustering (93). Initially, one or more
points (seeds) are assigned in each of the segments either manually or automatically. In
each iteration, the pixels around a seed point are examined and determined whether each
pixel belongs to the segmentation class (segment). If yes, this pixel is added to the seeds
of that segment. The choice of criterion by which a pixel is allocated to a segment has an
impact on the final result of segmentation. For example, one criterion is to choose a pixel
as a member if its grayscale value is close to the average grayscale values of the region.
The definition of “closeness” can also influence the results. In many applications,
closeness is defined as a distance smaller than 1-3 times the standard deviation of the
pixels’ intensity values in the region. This process continues until all the pixels in the
image are allocated to one and only one of the growing regions (93).

1.7

«Image Registration»

Image registration is defined as the process of aligning two or more images taken from
the same scene under different conditions, e.g. images taken from a landscape from
slightly different angles or viewpoints, CT images taken from a tumor before and after
the course of treatment, the MR and the CT taken from a patient’s brain, etc. Image
registration involves designating one of the images as the fixed (reference) image, while
the other image is assigned as the moving image. The geometric transformations and/or
local displacement fields are applied to the moving image so that it aligns with the fixed
image (94,95). Usually, image registration is performed as a preliminary step to prepare
the images for another image processing algorithm. For example, the CT images acquired
from the patient’s lung at end-exhalation phase is registered to the image of the same
patient’s lung at end-inhalation phase to extract and quantify certain pathophysiological
conditions (96).
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Based on the process that was involved between the acquisition of the two images, a
combination of different transformations might be required to register the images. The
transformation can be rigid (translation and rotation), affine (rigid + scaling and
shearing), or deformable registration (2-3 degrees of freedom for each pixel). Figure 1-11
shows the flowchart of a registration algorithm. There are essential components to any
image registration algorithm (97). A metric is used to compare the closeness of the
moving and the fixed image after a transformation. Proper choice of the metric can have a
significant impact on the performance and the results of the registration. Commonly used
metrics include: mean squared errors, normalized cross correlation, and normalized
mutual information. The latter is the best choice for multi-modality image registration
(e.g. between MR and CT). An optimizer is required to find the minimum (or maximum,
based on the choice of metric) of the metric that will result in the best alignment of the
two images. Choosing the proper optimizer and its parameters (e.g. step size, relaxation
factor, etc.) can be very important for performance of the registration algorithm. The
interpolators are used for calculating the pixels grayscale values after transformation.
When the image is transformed, the pixels may land on non-integer locations (i.e. not on
the fixed image grid). Therefore, an interpolator is required to reconstruct the transformed
image.
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Virtual Image

Figure 1-11. Flow chart of a general registration algorithm. A metric is used to compare
the fixed image with the moving image after each time the moving transform is updated.
The optimization stops when the metric or changes in the metric are smaller than a
predefined limit. The virtual image is reconstructed after the optimization is completed.

Adapted from The ITK Software Guide Book 2 Fourth Edition, by Johnson H.J.,
McCormick M.M., Ibáñez L., and the Insight Software Consortium.

1.8

«Theory of Elasticity»

Elasticity is a property of solid materials to regain their original shape after an external
force is removed. Theory of elasticity describes the mechanical behavior (i.e. deformation
and failure) of the elastic materials under the application of external force. Continuum
mechanics deals with the mechanical behavior of materials that can be considered as a
continuous mass rather than discrete parts or particles and is therefore based on the
continuum hypothesis: “matter is continuously distributed, and regardless of how small
volume elements the matter is subdivided into, every element will contain matter. The
matter may have a finite number of discontinuous surfaces, for instance fracture surfaces
or yield surfaces, but material curves that do not intersect such surfaces, retain their
continuity during the motion and deformation of the matter” (98).
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A continuum is characterized by a mass 𝑑𝑚, contained in an elementary volume 𝑑𝜏 =
𝑑𝑚
𝜌

. 𝜌 is referred to as the mass density. A material continuum occupying a volume 𝑣

with a surface 𝑜 (initial state), will reach a new equilibrium state with the volume 𝑉 and
the surface 𝑂 (final state). The position of the material particle is defined in a Cartesian
coordinate as (the summation over the dummy index 𝑠 is omitted for brevity):
𝑿 = 𝑎1 𝒊1 + 𝑎2 𝒊2 + 𝑎3 𝒊3 = 𝑎𝑠 𝒊𝑠 ,

(5)

where 𝒊𝑠 is the base unit vector of the coordinate axes. Similarly, the final state of the
material particle is:
𝒙 = 𝑥1 𝒊1 + 𝑥2 𝒊2 + 𝑥3 𝒊3 = 𝑥𝑠 𝒊𝑠 .

(6)

The displacement vector moving the material particle from the initial state to the final
state is:
𝒖 (𝑿, 𝑡) = 𝒙(𝑿, 𝑡) − 𝑿,

(7)

𝒖 (𝑿, 𝑡) = 𝑢1 𝒊1 + 𝑢2 𝒊2 + 𝑢3 𝒊3 = 𝑢𝑠 𝒊𝑠 ,

(8)

𝑢𝑠 = 𝑥𝑠 − 𝑎𝑠 .

(9)

which can be written as:

and therefore:

See Figure 1-12.
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Figure 1-12. A particle in the elastic geometry at its initial state (𝑿), displaced by
𝒖 (𝑿, 𝒕) to its final state (𝒙(𝑿, 𝒕)).
The displacements, i.e. the projections of the displacement vector (i.e. 𝑢𝑠 ), are functions
of the initial position of the material particle (𝑎𝑠 ), and hence the dependence of 𝒖 on 𝑿 in
Eq. 7. For the equation to have a unique solution, the Jacobian (Eq. 10) must not vanish
in the closed domain 𝑣 + 𝑜.
𝜕𝑢1
𝜕𝑎1
|
𝜕𝑥𝑠
𝜕𝑢𝑠
𝜕𝑢2
𝐽 (𝑎1 , 𝑎2 ¸𝑎3 ) = |
| = | 𝛿𝑠𝑘 +
|=
𝜕𝑎𝑘
𝜕𝑎𝑘
𝜕𝑎1
| 𝜕𝑢
3
𝜕𝑎1
1+

𝜕𝑢1
𝜕𝑎2
𝜕𝑢2
1+
𝜕𝑎2
𝜕𝑢3
𝜕𝑎2

𝜕𝑢1
𝜕𝑎3 |
𝜕𝑢2
.
𝜕𝑎3
𝜕𝑢3 |
1+
𝜕𝑎3

(10)

The Jacobian (𝐽) is the deformation gradient tensor, also denoted by 𝑭. 𝑭 can be rewritten as:
𝑭 = 𝑰 + ∇𝒖,

(11)

where ∇𝒖 is the displacement gradient, and 𝑰 is the identity tensor. The following
equation is derived from Eq. 7 and Eq. 11 using differential calculus principles:
𝑑𝒙 = 𝑑𝑿 + (∇𝒖)𝑑𝑿 = 𝑭𝑑𝑿,

(12)
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where 𝑑𝒙 and 𝑑𝑿 are the distance between two infinitesimally close points in the final
and initial volumes. Therefore, the square of the linear elements (i.e. the inner product of
the distance 𝑑𝒙 with itself) in the final volumes becomes:
𝑑𝑠 2 = 𝑑𝒙. 𝑑𝒙 = 𝑑𝑿𝑭𝑻 𝑭𝑑𝑿.

(13)

We substitute 𝑪 = 𝑭𝑻 𝑭, and obtain
𝑑𝑠 2 = 𝑑𝑿𝑪𝑑𝑿,

(14)

where 𝑪 is called the right Cauchy-Green deformation tensor. In distance-preserving
transformations (e.g. rigid body motion), 𝑑𝑠 2 = 𝑑𝑿. 𝑑𝑿 and therefore 𝑪 = 𝐼. Substituting
Eq. 11 in Eq. 13 we can find the relationship between the right Cauchy-Green
deformation tensor and the displacement gradient:
𝑪 = (𝑰 + 𝛻𝒖)𝑇 (𝑰 + 𝛻𝒖) = 𝑰 + 𝛻𝒖 + (𝛻𝒖)𝑻 + (𝛻𝒖)𝑻 (𝛻𝒖).

(15)

𝑬 is the Green-Lagrange strain tensor and is calculated from the displacement as:
𝑬=

1
[𝛻𝒖 + (𝛻𝒖)𝑻 + (𝛻𝒖)𝑻 (𝛻𝒖)].
2

(16)

Therefore:
𝑪 = 𝑰 + 2𝑬.

(17)

To obtain the Green-Lagrange strain tensor from the deformation gradient tensor F, we
can use 𝑪 = 𝑭𝑻 𝑭 and Eq. 17:
𝐸=

1 𝑻
[𝑭 𝑭 − 𝑰].
2

(18)

The advantage of using this formulation to calculate the Green-Lagrange strain tensor is
that it uses the reference body configuration instead of the deformed (final) state.
To obtain the strain values in all directions at each point from displacements, we start
with the simple case and assume that the displacements (and their partial derivatives) are
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small. In this case, in Eq. 16 the higher order term (𝛻𝒖)𝑻 (𝛻𝒖) becomes negligible, and
we can simplify the strain tensor to the infinitesimal strain tensor:
𝜺=

1
[𝛻𝒖 + (𝛻𝒖)𝑻 ].
2

(19)

Now the strain values can be obtained from displacements in the Cartesian coordinate as:

𝜀𝑖𝑗 =

𝜕𝑢𝑗
1 𝜕𝑢𝑖
(
+
).
2 𝜕𝑿𝑗 𝜕𝑿𝑖

(20)

This formulation can be used to calculate strains from displacement when the
deformation of the elastic material under the external force is infinitesimal, and no
intrinsically nonlinear elastic behavior is expected from the material.
In cases where the material undergoes large deformations, we can no longer ignore the
higher order terms in the calculation of the strain tensor. The strain components can
therefore be calculated as:

𝐸𝑖𝑗 =

𝜕𝑢𝑗
1 𝜕𝑢𝑖
1 𝜕𝑢𝑚 𝜕𝑢𝑚
(
+
)+
, 𝑚 = 1,2,3.
2 𝜕𝑿𝑗 𝜕𝑿𝑖
2 𝜕𝑿𝑖 𝜕𝑿𝑗

(21)

To formulate the mechanical behavior of the material under external forces, the
relationship between the stress tensor and the strain tensor should be described. In this
regard, the internal traction vector 𝒕 of a force 𝑭 that acts on a plane is defined as:
𝒕=

𝑑𝑭
𝑑𝐴

(22)

where 𝑑𝐴 is a very small differential area on the plane where the force 𝑑𝑭 is applied. The
vector 𝒕 can be expressed in terms of components of true (Cauchy) stress. For each
component of 𝒕 normal to each face of the infinitesimal cube (𝒕𝑵𝟏 , 𝒕𝑵𝟐 , 𝒕𝑵𝟑 ) (Figure 1-13),
the corresponding stress components are used:
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𝒕𝑵𝟏 = 𝜎11 𝑵𝟏 + 𝜎12 𝑵𝟐 + 𝜎13 𝑵𝟑
{ 𝒕𝑵𝟐 = 𝜎21 𝑵𝟏 + 𝜎22 𝑵𝟐 + 𝜎23 𝑵𝟑 ,
𝒕𝑵𝟑 = 𝜎31 𝑵𝟏 + 𝜎32 𝑵𝟐 + 𝜎33 𝑵𝟑

(23)

𝒕𝑵𝒊 = 𝜎𝑖𝑗 𝑵𝑗 , 𝑖 ∈ {1,2,3} 𝑎𝑛𝑑 𝑗 ∈ {1,2,3}.

(24)

Or in a compact form:

In these equations, 𝑵𝑗 is the unit vector normal to the corresponding face of the
infinitesimal cube (Figure 1-13).

Figure 1-13. The infinitesimal cube and the unit vectors normal to its surfaces, used for
calculating internal traction.
Having the relationship between the internal traction vector for each particle (cube as in
Figure 1-13) and the components of the Cauchy stress, we can write the equilibrium of
force for the cube, that is the infinitesimal volume of the continuum material. Newton’s
second law must be satisfied for the infinitesimal cube, hence the following equation
shows the equilibrium per unit volume of the cube:
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𝜕𝒕𝑁1 𝜕𝒕𝑁2 𝜕𝒕𝑁3
+
+
+ 𝜌𝑩 = 𝜌𝒂,
𝜕𝑥1
𝜕𝑥2
𝜕𝑥3
𝑜𝑟 ∶

𝜕𝒕𝑁𝑗
𝜕𝑥𝑗

+ 𝜌𝐵𝑗 𝑁𝑗 = 𝜌𝑎𝑗 𝑁𝑗 ,

𝑗 𝜖 {1,2,3},

(25)

(26)

Where B is the body force per unit mass through the continuum. We use the Cauchy
stress representation of 𝒕𝑁𝑗 , and we can write the equilibrium equation as follows:
𝜕𝜎𝑖𝑗
+ 𝜌𝐵𝑖 = 𝜌𝑎𝑖 , 𝑖 𝜖 {1,2,3} 𝑎𝑛𝑑 𝑗 𝜖 {1,2,3}.
𝜕𝑥𝑗

(27)

The above equation in the tensor form is:
𝑑𝑖𝑣 𝝈 + 𝜌𝑩 = 𝜌𝒂.

(28)

The above equation is called the Cauchy’s equation of motion that describes the
deformation of the continuum body.
To find the mechanical behavior of an elastic material under external forces, we need
information about the mechanical properties of the material, e.g. its stiffness and
incompressibility that define its active deformation pattern due to specific loading
conditions. Typically, the intrinsic mechanical behavior of the material is represented by
a relationship between the generated stresses and the strains in the continuum body. This
relationship is known as a constitutive law.

1.8.1

Linear Elasticity

The constitutive law for linear elastic materials is given by the Hook’s law. Hook’s law
defines the relationship between the components of Cauchy stress (𝜎𝑖𝑗 ), and the
components of the strain tensor (𝜀𝑘𝑙 ) for continuum material particles as:
𝜎𝑖𝑗 = 𝐶𝑖𝑗𝑘𝑙 𝜀𝑘𝑙,

(29)
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where 𝐶 is known as the elasticity tensor and is of order 4. The elasticity tensor has 34 =
81 entries, however, 21 of which are enough to fully characterize the elastic behavior of
the material. When the material is isotropic and linear elastic, Hook’s law is simplified to
(in tensor form):
𝝈 = 𝜆𝜀𝑘𝑘 𝑰 + 2𝜇𝜺,

(30)

where 𝜆 and 𝜇 are Lame’s constants. The Lame’s constants are defined in terms of the
stiffness (Young’s modulus, 𝐸) and the incompressibility (Poisson’s ratio, 𝜐):
𝜆=

𝜐𝐸
,
(1 + 𝜐)(1 − 2𝜐)

𝜇=

𝐸
.
2(1 + 𝜐)

(31)

Equations 29 and 30 can fully describe the mechanical behavior of an isotropic linear
elastic material under external forces.

1.8.2

Hyperelasticity

Many of the materials do not exhibit linear elastic response under external loading
conditions. The nonlinear behavior of materials can be attributed to either or a
combination of two mechanisms: intrinsic nonlinearity, and geometric nonlinearity.
Hyperelasticity is used to explain the mechanical behavior of materials involving both
mechanisms. Intrinsic nonlinearity, as the name suggests, is due to intrinsic mechanical
properties that are defined by the properties of the material constituents. Materials with
intrinsic nonlinearity are described by a nonlinear relationship between the Cauchy
stresses and the strain tensor components under loading. Geometric nonlinearity arises
from the change in the mechanical response caused by a force equilibrium alteration
resulting from change in the material geometry. The change in the material geometry
typically occurs when the material undergoes large deformations (strains > 5%) due to
external loading, and results in a redistribution of forces within the material.
In hyperelastic materials, the mechanical behavior is characterized in terms of a strain
energy function, because hyperelastic materials may store deformation work as elastic
energy (strain energy). The strain energy function is therefore defined in the deformation
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gradients (𝐹) space, as energy per unit volume. The constitutive law of the material is
derived according to the strain energy function, and for that purpose we can write the
equation that relates the Cauchy stress tensor (𝝈) to the density energy function (𝑈(𝑭))
and the deformation gradient tensor (𝑭) and its determinant (𝐽):
𝝈 = 𝐽−1 𝑭

𝑑𝑈(𝑭)
.
𝑑𝑭

(32)

When the hyperelastic material is isotropic, the determinant of deformation gradient is
one, and the above equation in this case becomes:
𝝈 = −𝑝𝑰 + 𝑭

𝑑𝑈(𝑭)
,
𝑑𝑭

(33)

where 𝑝 is an indeterminate Lagrange multiplier. The constitutive law for the isotropic
hyperelastic materials can be derived from the above equation in terms of the strain
energy function as:
𝝈 = 2𝐽−1 [𝐼3

𝜕𝑈
𝜕𝑈
𝜕𝑈
𝜕𝑈 2
𝑰+(
+ 𝐼1
)𝑩 −
𝑩 ],
𝜕𝐼3
𝜕𝐼1
𝜕𝐼2
𝜕𝐼2

(34)

where B (not to be confused with B in Eq. 25) is the left Cauchy-Green deformation
tensor, defined in terms of the deformation gradient tensor as:
𝑩 = 𝑭𝑭𝑇 .

(35)

The strain energy function (𝑈) is a function of 𝐼1 , 𝐼2 , and 𝐼3 , i.e. the strain invariants of
the Cauchy-Green deformation tensors:
𝐼1 = 𝑡𝑟(𝑩) = 𝜆12 + 𝜆22 + 𝜆23
2

(36)

𝐼2 = 0.5 [(𝑡𝑟(𝑩)) − 𝑡𝑟(𝑩𝟐 )] = 𝜆12 𝜆22 + 𝜆12 𝜆23 + 𝜆22 𝜆23

(37)

𝐼3 = det(𝑩) = 𝐽2 = 𝜆12 𝜆22 𝜆23 .

(38)

In the above equations, 𝜆𝑖 , 𝑖 ∈ {1,2,3}, are the principal stretches.
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Using Eq. 34, the constitutive law for a material can be derived for a given strain energy
function. There are several different hyperelastic models that are represented by different
strain energy functions. These different hyperelastic models are used to characterize the
various mechanical behaviors of nonlinear elastic materials. In ABAQUS (the finite
element solver that we used in this project), several hyperelastic forms are implemented,
including: Arruda-Boyce, Marlow, Mooney-Rivlin, Neo-Hookean, Ogden, polynomial,
reduced polynomial, Van der Waals, and Yeoh. The appropriate strain energy form for a
material must be chosen based on mechanical test data. In this project, the Yeoh
hyperelastic form was chosen to model the mechanical behavior of the lung tissue under
deformation. The Yeoh strain energy function is described as:
3

𝑈 = ∑ (𝐶𝑖0 (𝐼1 − 3)𝑖 +
𝑖=1

1
(𝐽 − 1)2𝑖 ) ,
𝐷𝑖

(39)

where 𝐶10 , 𝐶20 , and 𝐶30 are the hyperelastic parameters and 𝐷1 , 𝐷2 , and 𝐷3 are the
incompressibility coefficients. From the strain energy function and Eqs. 34 to 38, the
stress-strain relationship can be obtained for the Yeoh hyperelastic form.

1.9

«Inverse Problem»

Using the complete description of a system from the governing physical theories, we can
make predictions of the outcome of measurements. Predicting the measurement results of
a system is known as the forward problem. On the other hand, using the results of
measurements of a system to infer the values of parameters that describe the system is
referred to as inverse problem. Unlike the forward problem, the inverse problem does not
typically have a unique solution. In this work, to develop the biomechanical model of the
lung based on the information from 4DCT, we have designed and implemented an
inverse problem formulation. The parameters of the lung biomechanical model (the
forward model) are found based on the information from 4DCT (results of
measurements). For more detailed information on the inverse problem, see Section 2.2.3.
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1.10

«Research Objectives»

The work presented in this thesis is mainly focused on two objectives:
1. Development of an accurate lung biomechanical model for tumor motion and
deformation estimation by incorporating pathology-induced heterogeneity.
2. Development of a 4DCT-based ventilation imaging technique using a
biomechanical model-based image registration and an accurate air segmentation
algorithm, as well as validation of the proposed ventilation imaging technique
using hyperpolarized 3He MR.

1.11

«Thesis Outline»

This thesis is organized to include four chapters. The current chapter is dedicated to
introduction and background, while the following two chapters describe the details of the
work towards achieving the two main objectives mentioned in the above section,
followed by the final chapter which is dedicated to summary and concluding remarks.

1.11.1

Chapter 2: A Patient-Specific Heterogeneous Biomechanical
Model of the Lung for Accurate Tumor Motion Estimation

In this chapter, we describe details of the work towards achieving the first objective of
the thesis. A patient-specific lung biomechanical model is developed from 4DCT scans.
This lung biomechanical model is patho-physiologically realistic as it incorporates the
heterogeneity in the lung tissue mechanics caused by co-existing chronic obstructive
pulmonary disease (COPD). Advanced image processing methodologies such as semiautomated segmentation of the lung images, free-form deformation image registration
algorithm, semi-automated boundary conditions extraction, and COPD phenotypes
quantification algorithm were designed and implemented and/or employed to extract the
information from 4DCT scans, required to build the biomechanical model. An inverse
problem formulation was designed and employed to obtain the parameters of the
biomechanical model, e.g. the coefficients determining the amplitude of the pressure that
inflates the lungs, and the mechanical properties of the lung tissue affected by COPD
phenotypes. The lung biomechanical model is used to estimate the motion and
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deformation of the tumor. The simulation results were compared against the actual
location and shape of the tumor extracted from 4DCT using measures of similarity and
distance. The high accuracy of the model for tumor motion and deformation estimation
indicates successful achievement of the first objective of the thesis.

1.11.2

Chapter 3: 4DCT Ventilation Imaging Using Biomechanical
Model-based Deformable Registration

In this chapter, we explain the details of the work towards achieving the second objective
of the thesis. We developed a 4DCT-based ventilation imaging technique using a novel
method that utilizes a biomechanical model-based DIR along with an accurate air
segmentation algorithm. 4DCT scans of patients diagnosed with NSCLC and planned for
RT were used to build patient-specific biomechanical models of the lungs. In this model,
the lung geometry used for finite element (FE) meshing was acquired from segmenting
the CT volume at end-exhalation. Loading was defined in terms of the transpulmonary
pressure expanding the lungs. Boundary conditions consisted of the diaphragm motion
and anatomical fixed points for each patient. The pressure amplitude and mechanical
properties of various tissue volumes of the lung were found through an optimization
algorithm designed to maximize the accuracy of the biomechanical model. The
biomechanical model was used to deformably register the end-exhale scans to the endinhale ones. The biomechanical model-based DIR tracks air motion in the lung. The air
segmentation algorithm, previously developed in our lab and enhanced in this work,
found subject-specific thresholds for the inhalation and exhalation CT scans. This air
segmentation algorithm also accounts for the partial volume effect, hence providing
accurate estimations of the air volume inside the voxels. Having the air motion from DIR,
and the air volume in each voxel, we can calculate the ventilation. To have a more
accurate estimate of ventilation, we also took into account the regional volume expansion
due to the inflow of air. We used the change in the volume of the mesh elements during
finite element analysis to obtain the volume expansion at voxel level. The final 4DCT
ventilation images were qualitatively and quantitatively compared against 3He MR
images for validation.
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1.11.3

Chapter 4: Discussion and Conclusion

In the final chapter, we summarize the findings of the thesis, and discuss the limitations
of the proposed algorithms. We also discuss possible future directions and suggestions
for further studies. This section lastly concludes this dissertation.
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Chapter 2

2

« A Patient-Specific Heterogeneous Biomechanical
Model of the Lung for Accurate Tumor Motion
Estimation »

Currently, one of the main components of lung cancer treatment is radiation therapy (RT)
which suffers from inaccuracies caused by the complex intrafraction respiratory motions.
One potential solution towards addressing this challenge is to develop a lung
biomechanical model capable of predicting the tumor’s motion/deformation. Chronic
obstructive pulmonary disease (COPD) commonly coexists with lung cancer and is
associated with extensive heterogeneity in the lung parenchyma; however, current
methods lack this key component. In this work, we have developed an accurate lung
biomechanical model that accounts for COPD-induced heterogeneities in the lung
structure. Four-dimensional computed tomography (4DCT) images were used to build a
patient-specific finite element (FE) model, and to identify inhomogeneity inside the
model. Mechanical properties of pathological volumes inside the lung, and the maximum
amplitude of the pressure driving the respiratory motion are determined through an
optimization algorithm that aims at maximizing the similarity between the actual and
simulated tumor and lung volume images. Results obtained in this work suggest that the
accuracy of the tumor motion estimation model increases considerably when
incorporating the patho-physiological heterogeneity, compared to the homogeneous
model counterpart.

2.1

« Introduction »

Lung cancer remains the most common type of cancer affecting men and women, both in
terms of incidence and mortality (1). Concurrent chemotherapy and radiation therapy
(RT) is the current standard treatment for inoperable non-small cell lung cancer
(NSCLC)(1–3). Stereotactic body radiation therapy (SBRT) is a high-precision treatment
technique for extracranial tumors that delivers potent doses of highly focused radiation
beams during a single or a few radiation fractions (4). Recently developed advanced
SBRT methods such as intensity modulated RT (IMRT) and volumetric modulated arc
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therapy (VMAT), aim at increasing the tumor control probability (TCP), and lowering
normal tissue complication probability (NTCP) by delivering a more accurate and highly
conformal radiation dose (5,6). IMRT utilizes forward or inverse radiation treatment
planning to determine and deliver the necessary dose distribution through the use of
multileaf collimators (7). VMAT is a more advanced type of IMRT that decreases the
delivery time by applying the dose in a single gantry arc movement and improves the
dose conformality by using the full 360° range of gantry rotation (8,9). However,
respiratory motion can cause inaccuracies in RT, resulting in higher probabilities of
treatment complications such as irradiating normal tissue and undesirable dose
distribution in the target tumor (7,10). Methods have been proposed to reduce such
inaccuracies in RT, including: motion encompassing (11), breath-hold techniques (12),
and gating the radiation beam with the breathing cycle (13,14). Each of these methods
suffer from inherent limitations. In motion encompassing, the planning target volume is
expanded to encompass the entire clinical target volume, resulting in a higher radiation
dose delivery to normal tissue. Breath-hold methods are not usually well tolerated by
lung cancer patients. Gated radiotherapy procedures are intrinsically associated with a
conflict between the gating efficiency and gating window time, and longer radiation
sessions. This problem is particularly of importance in IMRT systems where the
treatment times are inevitably longer.
An alternative solution to improve the precision in radiation delivery is to synchronize
the radiation beam with the tumor motion. Accordingly, strategies to account for
respiratory motion that provide accurate information regarding real-time shape and
location of the target tumor are in demand. Intensity-based deformable image registration
(DIR) methods have been employed to estimate the deformation field of the lung and the
respiratory tumor motion for dose calculation and treatment planning purposes (15–17).
However, the application of DIR methods in real-time tumor tracking is limited to a few
studies. Li R. et al. adapted deformable image registration (DIR) in conjunction with
simultaneous x-ray imaging to estimate the lung tumor motion and deformation (18);
however, the extra radiation dose imposed to the patient due to the x-ray imaging in these
methods has raised some concerns (19). In addition, intensity-based DIR methods are
solely based on four-dimensional computed tomography (4DCT) image data. These
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methods do not take into account the physical properties or physiological mechanisms
involved in breathing. Therefore, they are prone to errors associated with non-uniqueness
of the resulting displacement field, and registration errors in areas with low image
contrast. Handling the sliding motion of the lungs can also be challenging for motion
estimation using intensity-based DIR methods (20,21).
Biomechanics-based computational modelling is another commonly used approach for
respiratory tumor motion estimation. In contrast to DIR, biomechanics-based
computational models encompass certain aspects of breathing dynamics, rendering this
approach more robust and realistic (22–26). Patient-specific biomechanical models of the
lung that use thoracic image data to extract the geometry and boundary conditions have
previously been proposed (22,23,26,27). Several studies investigated the effects of model
parameters including the mechanical properties (27–29), and boundary conditions (25) on
modeling accuracy. Recently, hybrid hierarchical approaches have been proposed, in
which finite element (FE)-based biomechanical models are used in conjunction with
intensity-based DIR methods to predict deformation field of the lung in a respiratory
cycle (21,30,31).
Biomechanical modeling of the lung is capable of respiratory tumor motion estimation
without requiring simultaneous imaging during RT or implanting invasive fiducial
markers inside the tumor. Our group recently proposed a hybrid motion model for realtime estimation of tumor location/geometry during respiration (32). The proposed method
translates the chest surface motion data obtained by optical tracking markers to the tumor
location/geometry, using the patient-specific biomechanical model of the lung and a
predictive function. A realistic and accurate biomechanical model of the lung is,
however, required in this method for real-time tracking of the tumor with a desired
precision.
Tissue mechanical properties including tissue stiffness and incompressibility, are
important features of a biomechanical model determining its behavior under loadings.
The air volume inside the lungs varies significantly during a respiration cycle, therefore,
changes in tissue incompressibility is expected. Shirzadi et al. were first to investigate the
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variations of incompressibility of the lung throughout respiration (29). Their results
demonstrated that accounting for variable incompressibility throughout respiration in a
biomechanical model of the lung leads to higher accuracy of tumor motion estimation.
More than 65% of lung cancer patients also suffer from chronic obstructive pulmonary
disease (COPD) (33,34). COPD is a heterogeneous disease, characterized by multiple
phenotypes including small airways disease (SAD) and parenchymal destruction
(emphysema) that cause changes in the structure and mechanical properties of the
affected lung tissue (35–38). A characteristic manifestation of emphysema is the
interactions that occur between the immune system and the mechanical properties of the
lung parenchyma at the microstructure level. The former causes inflammatory responses
resulting in tissue remodeling, and therefore alterations in the mechanical properties of
the affected areas in the lung tissue under repeated breathing cycles. A biomechanical
model that accounts for local changes in tissue material properties potentially results in a
more realistic motion estimation. Although few studies have been conducted to measure
mechanical parameters of the lung tissue (39,40) or to evaluate the effect of changes in
tissue mechanical properties on the model accuracy (23,41,42), to our knowledge, a
tumor motion/deformation estimation model accounting for pathology-induced local
changes in mechanical properties of the lung has not been reported.
In this study, we propose a novel biomechanical model of the lung for respiratory tumor
motion prediction that accounts for pathology-induced heterogeneities within the lung
tissue. For this purpose, a patient-specific FE model of the lung was developed using
4DCT image data. The pathological regions pertaining to COPD phenotypes were
quantified using the CT image data. Tissue sub-types pertaining to healthy and various
pathological phenotypes were considered in the model. The CT image of the lung at endexhalation (EE) was registered to the CT image of all phases of respiration (e.g. endinhalation: EI) using the FE model by optimizing the parameters of loading and
mechanical properties of the tissue sub-types.
The effect of incorporating pathology-induced heterogeneity on the model performance is
investigated by comparing the accuracy of the tumor motion estimation of the
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heterogeneous model with that of a homogeneous counterpart. Results of the similarity
measures between the simulated and actual tumor volumes, as well as the average
landmark error demonstrated that incorporating the pathology-induced tissue
inhomogeneities can improve the model accuracy and reliability considerably.

2.2
2.2.1

« Materials and Methods »
Data Acquisition

This research was performed in accordance with the institutional research ethics board
approval. 4DCT respiratory image sequences of 5 patients were acquired as part of the
FLAIR trial (10). Patients were diagnosed with NSCLC and planned for IMRT or
volumetric-modulated arc therapy (VMAT) using PINNACLE (v9.6) Radiation Therapy
Planning System (Philips Medical Systems, Fitchburg, WI). Patients were scanned using
a 16-slice Philips Brilliance Big Bore CT scanner (Philips Medical Systems) operating in
helical mode. The scan parameters were: 120kVp and 400mAs/slice for tube potential
and current, respectively. The intra-slice pixel size of the data varied from 1.0 mm × 1.0
mm to 1.1 mm × 1.1 mm, and the slice thickness was 3 mm for all scans.
The 4DCT images were sorted into 10 respiratory phases using the Real-time Position
ManagementTM system. The phases were labeled as: 0%, 10%, 20%, etc. to 90%, with
0% denoting the EI phase and 50% denoting the EE phase. In this study, efforts were
made to include patients with various tumor sizes and locations inside the lungs to
explore the reliability and robustness of the biomechanical model. The average tumor
size was 18.1 cm2, ranging from 4.1 cm2 to 61.9 cm2. In addition, the extent of COPDrelated phenotypes including gas trapping and airway wall destruction varied between the
patients.

2.2.2

Patient-specific Biomechanical Model

To develop the patient-specific biomechanical model, the lung geometry, tissue
mechanical properties, loadings, and boundary conditions are required. The
heterogeneous and homogeneous models were similar in terms of the procedures
involved in obtaining the model geometry, boundary conditions, and spatial pattern of the
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loading. In the heterogeneous model, areas affected by either of the COPD phenotypes,
the tumor, and the healthy lung parenchyma were assigned different mechanical
properties. In the homogeneous model the entire lung parenchyma was modeled with one
set of mechanical properties, with only the tumor assigned a separate set of properties.
Further details on each model have been provided below.

2.2.2.1

Patient-specific Model Geometry

The 3D CT volume at EE (50%) phase was used to obtain the model geometry for each
patient. The lungs were segmented using a region growing-based segmentation method
followed by opening and closing operations for smoothing purposes. The automatic
segmentation was an extension to the semi-automatic algorithm previously developed by
our group (29,43). The 3D model of the lung was created from the closed lung
segmentation mask using the open source 3D Slicer software package (44). The IAFEMesh software package (MIMX, Iowa city, IA, USA) was used to generate volumetric
FE mesh of the lung with 8-node hexahedral elements. The FE analysis was performed
using the ABAQUS/Standard software (ABAQUS Inc., Pawtucket, RI).

2.2.2.2

Loadings and Boundary Conditions

In a respiratory cycle, the lungs start to expand from EE in response to 1) contraction of
the diaphragm, and 2) contraction of external intercostal muscles that expands the chest
cavity, consequently resulting in a drop in the transpulmonary pressure, P T. At EI, the
respiratory muscles (diaphragm and external intercostal) relax, causing the diaphragm to
return and the ribcage to fall. This leads to an increase in the PT, forcing the air out of the
lungs. The extent of expansion, and therefore the PT varies for different phases of
respiration. In addition, PT is not spatially uniform on the lung surface. Accordingly, in
the biomechanical model, the loadings were defined in terms of the net pressure required
to expand the lungs from relaxed phase (EE), to the target phase of respiration, i.e. the PT.
The PT was applied with a linearly increasing gradient in the posterior to anterior
direction.

For each patient, the maximum pressure amplitude for each phase of

respiration was estimated through an optimization algorithm. Details on the optimization
process, the cost function, and the evaluation criteria are described in Section 2.2.3.
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The drop in the PT mainly enlarges the lungs in the medial-lateral (ML) and anteriorposterior (AP) directions whereas the diaphragm is known to cause 60-80% of the
thoracic cavity enlargement (60), and hence playing an important role in the lung
expansion during inspiration. In this study, the displacement of the diaphragm resulting
from its contraction was estimated through a non-rigid registration algorithm. A multiresolution free form deformation (FFD) algorithm was used to register the relaxed
diaphragm at EE to the contracted diaphragm at other respiration phases. The resulting
displacement field was then applied in the FE model as prescribed boundary condition at
the bottom surface of the lung. Considering the fact that the diaphragm motion is a main
source of the lung deformation in the superior-inferior (SI) direction, the precision of the
diaphragm-driven prescribed boundary conditions is crucial. However, clinical 4DCT
image data acquired for radiation therapy planning are often low contrast and include
breathing-induced artifacts that affects image interpretation, especially within the areas
close to the diaphragm surface as shown in Figure 2-1(45,46). Yamamoto T. et al. have
investigated and classified the different types of artifacts attributed to internal motion of
the organs during the 4DCT acquisition, and explained the complications such artifacts
can cause in RT procedures (46).

(a)

(b)

(c)

Figure 2-1. Examples of motion-induced artifacts in the dataset. The images show

different types of artifacts as classified by Yamamoto et al. (a) Overlapping structure, (b)
incomplete structure, and (c) duplicate structure.

To evaluate the robustness of the proposed biomechanical model, cases with considerable
artifacts on and near the diaphragm were included in this study. Although the FFD
algorithm fails to register the EE diaphragm to that of another target phases (see Section
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2.3.2), it captures the relative spatial pattern of deformation. The major component of the
diaphragm displacement is in the SI direction. To compensate for the partial registration
due to image artifacts, the diaphragm displacement field was modified using an adaptive
correction factor (𝐾𝐶𝐹 ) for the SI component of the estimated deformation field. The 𝐾𝐶𝐹
was optimized for each target phase of respiration. Details of the applied optimization
framework has been provided in Section 2.2.3.
The respiratory lung motion in the chest cavity is constrained within regions of the lung
apex and the lung-ribcage interface. To model such constraints and incorporate them as
boundary conditions in the biomechanical model, a semi-automatic image segmentation
algorithm that uses information on lungs sliding motion was developed. The algorithm
inputs the 3D CT volumes at extremities of respiration (50%, 0%, and 90%) and outputs
3 label maps representing areas corresponding to fixed boundary conditions (constrained
in all directions), ML-AP constrained, and SI constrained.

2.2.2.3

Mechanical Properties

To investigate the effects of incorporating pathology-induced heterogeneities on the
model performance, both homogeneous and heterogeneous models were developed for
each patient. The model geometry, loading configuration, and boundary conditions were
similar for both models.

2.2.2.3.1

Homogeneous Biomechanical Model

As for the mechanical properties of the homogeneous model, two material types were
defined: lung parenchyma, and the tumor. The tumor was modeled as a linear elastic
material. Taking into account the large deformation of the lungs during respiration the
lung tissue was modeled as hyperelastic, described by Yeoh strain energy density
function (47):
3

3

𝑈 = ∑ 𝐶𝑖0 (𝐼1̅ − 3)𝑖 + ∑
𝑖=1

𝑘=1

1 𝑒𝑙
(𝐽 − 1)2𝑘 ,
𝐷𝑘

(1)
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where 𝑈 is the strain energy potential, 𝐼1 , 𝐼2 , and 𝐼3 are strain invariants (invariants of left
Cauchy‐Green strain tensor), and 𝐽𝑒𝑙 is the elastic volume ratio (a fraction of the total
volume ratio 𝐽 in constant temperature conditions). The model parameters 𝐶𝑖0 (𝑖 = 1: 3)
and 𝐷𝑘 (𝑘 = 1: 3) determine the material’s mechanical response and its variations with
respect to strain. The coefficients 𝐶𝑖0 (𝑖 = 1: 3) for the lung tissue were calculated by
fitting the experimental stress-strain data found in the literature (40). 𝐷𝑘 parameters
mainly describe the material incompressibility and its dependence on deformation. The
tissue incompressibility modeling is described in Section 2.2.2.3.3.

2.2.2.3.2

Heterogeneous Biomechanical Model

To model the pathology-induced heterogeneities inside the lung parenchyma, the extent
of each COPD phenotype was first quantified in the 4DCT images, using a well-known
attenuation-based method. In this method, the image voxels in the EI scan with
attenuation values lower than -950 Hounsfield Units (HU), denote emphysema (48–52).
Similarly, areas in the EE image with attenuation values lower than -856 HU represent air
trapping. A deformable image registration was used to register the EI scan to the EE
counterpart. The registration transformation was applied to map the emphysematous
voxels to the EE image. Finally, the areas affected by SAD were determined as the air
trapping voxels that are not caused by emphysema as illustrated in Figure 2-2.
The diseased volumes were subsequently incorporated in the FE analysis by assigning
different mechanical properties. The lung parenchyma was classified into 4 material subtypes: healthy, emphysematous, affected by SAD, and the tumor. The Yeoh hyperelastic
model was used to model the mechanical properties of healthy and diseased tissues
except the tumor. The elasticity coefficients (𝐶10 , 𝐶20 , and 𝐶30 ) for the healthy tissue
were the same as that of the lung parenchyma in the homogeneous model. The Yeoh
hyperelastic coefficients for each of the emphysema and SAD tissue sub-types were
optimized using an algorithm described in Section 2.2.3.
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(a-1)

(b-1)

(c-1)

(d-1)

(e-1)

(a-2)

(b-2)

(c-2)

(d-2)

(e-2)

Figure 2-2. Axial view of slices from 4DCT data showing emphysema (green), SAD
(yellow), and the tumor (red). Healthy lung parenchyma is represented by blue. (a)
Patient #1, with extensive SAD, less emphysema. (b) Patient #2, with extensive SAD,

less emphysema, very large tumor. (c) Patient #3, the tumor is located further from
COPD-affected volumes. (d) Patient #4, very less SAD and no emphysema. (e) Patient
#5, with extensive SAD and emphysema, tumor in proximity of affected areas.

2.2.2.3.3

Incompressibility Variation during Respiration

As previously described in the studies conducted by our group (29,43), lung tissue
incompressibility varies throughout respiration as the air content within the tissue
changes substantially between the inhalation and exhalation phases. In the previous
studies the variations in incompressibility of lung tissue was modeled by optimizing
Poisson’s ratio for each phase of respiration. Alternatively, the Yeoh hyperelastic model
applied in this study can describe the mechanical behavior of the lung at all respiration
phases with one set of 𝐶𝑖0 and 𝐷𝑘 parameters. Specifically, the 𝐷𝑘 parameters describe
the changes in tissue incompressibility with respect to variations in deformation during
respiration that are proportional to the air content of the lung. Therefore, optimizing the
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𝐷𝑘 parameters in the model accounts for the variable tissue incompressibility as a result
of changes in air volume of the lung during respiration.

2.2.3

Optimization Framework

A number of the biomechanical model parameters including maximum pressure
amplitude, diaphragm registration correction factor and the tissue mechanical properties
were optimized for each patient. The maximum pressure amplitude and the diaphragm
registration correction factor are parameters that depend on the phase of respiration and
should be optimized for each target phase separately. However, some of the mechanical
properties are phase-independent and must hold a consistent value throughout all phases
for each patient. The phase-independent mechanical properties include: the elasticity
parameters (𝐶𝑖0 s) for diseased sub-types in the heterogeneous model, and the
incompressibility parameters of the lung tissue for both the homogeneous and
heterogeneous models. On this basis, two optimization algorithms, one for the phasedependent and another for the phase-independent parameters were developed and used in
turn for both the homogeneous and heterogeneous models.
The first optimization algorithm was implemented in MATLAB (MathWorks, USA) for
computing the phase-dependent parameters; it is shown in Figure 2-3.The 4DCT scans
were segmented to obtain the lung and tumor geometries at 50% (𝜙50 ) and each target
phase (𝜙𝑖 , 𝑖 ∈ {0, 10,20,30,40,60,70,80,90}). Lung geometry at 𝜙50 was used as the
reference geometry to generate FE mesh for the analysis. The iterative FE analysis was
started using initial values for the transpulmonary pressure (𝑃𝑖 = −1.8 𝑐𝑚𝐻2 𝑂) and the
diaphragm registration correction factor (𝐾𝐶𝐹 𝑖 = 1) for each phase (𝜙𝑖 ). Since the
mechanical properties for the heterogeneous tissue sub-types are unknown at this point,
we started with the homogeneous material properties, simulating the deformation of the
lungs expanding from 𝜙50 to 𝜙𝑖 , and generating registered images, to 𝜙𝑖 . The
optimization cost function was formulated to minimize the Hausdorff surface-to-surface
distance (𝐻𝐷) between the actual (𝑇𝑟𝐴𝑗 ) and simulated (𝑇𝑟𝑆𝑗 ) tumor images, while
maximizing the Normalized Mutual Information (𝑁𝑀𝐼) within the lung in the actual
(𝐿𝑔𝐴𝑗 ) and simulated (𝐿𝑔𝑆𝑗 ) images:
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Figure 2-3. Flowchart showing the first optimization step. The 4DCT data is used to
segment the lung and the tumor at phase EE (𝝓𝟓𝟎 ) and the target phase, for which the
maximum pressure amplitude (𝑷𝒊 ) and the diaphragm registration correction factor
(𝑲𝑪𝑭𝒊 ) are optimized. The homogeneous finite element model is used in this step to
deform the reference geometry to the target counterpart. The cost function 𝒇𝑪 regulates
the updating of the parameters to ensure the best registration.
𝑓𝐶 (𝑃𝑖 , 𝐾𝐶𝐹𝑖 ) = 𝜆 × 𝐻𝐷 (𝑇𝑟𝐴𝑗 , 𝑇𝑟𝑆𝑗 ) +

𝛾
,
𝑁𝑀𝐼(𝐿𝑔𝐴𝑗 , 𝐿𝑔𝑆𝑗 )

(2)

where 𝜆 and 𝛾 are constants used as weight factors and were chosen to regulate the
relative effect of each measure (𝐻𝐷 and 𝑁𝑀𝐼) on the optimization based on their
importance and the range by which they vary.
After conducting this optimization step on the homogeneous model for all phases of
respiration individually, we can utilize the resulting pressure values in the second
optimization step for computing the phase-independent parameters, i.e. elasticity
properties and incompressibility. However, in determining the deformation, the pressure
and the mechanical properties are interrelated. Accordingly, fixing the pressure values to
what is obtained from the first step of the optimization when optimizing for mechanical
properties in the second step may lead to complications such as falling into local minima.
To account for the interrelation of pressure and mechanical properties, we must allow for
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the pressure to adjust during the second optimization process. In this regard, the pressure
values resulting from the first optimization are employed to form a parametric
representation of the pressure using Fourier series (Eq. 3). The Fourier representation
serves as a proper estimation of the pressure at each phase. This parametric representation
allows for optimization of the pressure through optimizing for the Fourier coefficients 𝑐1
and 𝑐2 . Therefore, amplitude of the pressure can be optimized in the second optimization
step as a function of time (i.e. respiration phase):
3

3

𝑃𝑇 (𝑡, 𝑐1 , 𝑐2 ) = 𝑐1 ∑(𝑎𝑛 𝑐𝑜𝑠 𝑛𝜔𝑡) + 𝑐2 ∑(𝑏𝑛 𝑠𝑖𝑛 𝑛𝜔𝑡),
𝑛=0

(3)

𝑛=0

where 𝑡 is time (respiration phase), 𝜔 represents base frequency, and 𝑎𝑛 and 𝑏𝑛 are the
relative amplitudes of different frequency components of sine and cosine functions.
The second optimization step was developed and utilized to compute the phaseindependent parameters in both homogeneous and heterogeneous models. In both cases,
𝑐1 and 𝑐2 (used to adjust the pressure) and the incompressibility parameters (𝐷𝑖 ) are
optimized. In the heterogeneous model the hyperelasticity coefficients for different tissue
material sub-types including 𝐶𝑖0𝐸𝑚𝑝ℎ𝑦𝑠𝑒𝑚𝑎 and 𝐶𝑖0𝑆𝐴𝐷 are also optimized. Information from
all phases of respiration are incorporated in each optimization iteration to accommodate
for optimization of phase-independent parameters. The cost function used for
optimization is consistent between the homogeneous and heterogeneous models. In each
iteration of optimization, the HD between the tumor images, and the NMI between actual
and simulated lung images for all target phases are calculated and combined as shown in
Eq. 4:
𝑓𝐶 (𝑐1 , 𝑐2 , 𝐷𝑖 , 𝐶𝑖0𝑘 )

𝑖∈{1:3},
𝑘∈{𝐸𝑚𝑝ℎ𝑦𝑠𝑒𝑚𝑎, 𝑆𝐴𝐷}

= 𝜆 × √∑ 𝐻𝐷2 (𝑇𝑟𝐴𝑗 , 𝑇𝑟𝑆𝑗 ) +
𝑗

𝛾
√∑𝑗 𝑁𝑀𝐼 2 (𝐿𝑔𝐴𝑗 , 𝐿𝑔𝑆𝑗 )

(4)
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2.3

« Results »

The heterogeneous and homogeneous models were implemented using 4DCT data of 5
patients. The model parameters were computed through the two-step optimization
algorithm. The optimized models were used to register the EE scan to other respiration
phases. The proposed algorithm is evaluated, and the accuracy of the homogeneous and
heterogeneous models for registration are compared.

2.3.1

Two-step Optimization Algorithm

The Fourier parametric representation of the maximum pressure amplitude obtained from
the first optimization step was evaluated in the first step. The coefficient of determination
(𝑅 2 ) and the normalized root mean square deviation (𝑁𝑅𝑀𝑆𝐷) of the Fourier estimation
of pressure for each patient are given in Table 2-1. The accuracy of the Fourier fitting is
reasonable for this application, because the estimated representation is used to assign
initial values for the second step of optimization.
Table 2-1 Evaluation results for the Fourier representation of optimized pressure.

2.3.2

Patient #

𝑅2

𝑁𝑅𝑀𝑆𝐷

1
2
3
4
5

0.9794
1
0.9791
0.9672
0.9932

0.1845
0
0.1233
0.1312
0.0621

Diaphragm FFD Registration Algorithm

Considering the important role of displacement boundary conditions determined by the
diaphragm registration on the modelling accuracy, we assessed the functionality of the
proposed method for correcting the diaphragm FFD registration. The registration
correction factor (𝐾𝐶𝐹 ) is optimized for each respiration phase during the first
optimization step. In some patients, the artifacts are more prominent than the others.
Figure 2-4 shows an example of the substantial improvement in diaphragm registration.
Figure 2-4(a) is the difference image between the source (EE phase) and target images
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before registration, Figure 2-4(b) illustrates the same after registration with FFD
algorithm, and Figure 2-4(c) shows the same after applying the 𝐾𝐶𝐹 to the deformation
field.

(a)

(b)

(c)

Figure 2-4. Difference image between diaphragm at EE (50%) and EI (0%), (a) before
registration, (b) after registration using FFD image registration, (c) after registration
using the optimized 𝑲𝑪𝑭 parameter applied to the deformation field.

2.3.3

Tumor motion/deformation estimation and Registration
Accuracy

The accuracy of the image registration using the heterogeneous and homogeneous
biomechanical models were evaluated using various criteria. To evaluate the accuracy of
tumor registration, the tumor volumes from the actual and registered CT images were
compared for each target phase of respiration using the Dice similarity coefficient, and
Hausdorff surface-to-surface distance (HD). Figure 2-5 demonstrates the evaluation
results of tumor registration for each patient.
In all cases, the average Dice coefficient increased, and the HD decreased when the
heterogeneous model was used, which shows the positive impact of incorporating the
patho-physiological changes of the lung structure in the model. The extent to which the
accuracy of tumor motion/deformation estimation improved by using the heterogeneous
model was different among cases. We calculated the percentage volume (%V) of COPD
phenotypes (emphysema and SAD) in each case, as shown in Table 2-2. We also
calculated the percentage improvement in

the average

measures

of tumor

motion/deformation accuracy (Dice and HD) when the heterogeneous model is used
instead of the homogeneous model for each case. As show in Table 2-2, more tangible
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Figure 2-5. Comparing the results of tumor motion/deformation estimation between
homogeneous and heterogeneous models. (a) Average Dice similarity coefficient and
(b) average Hausdorff distance (HD) between actual and simulated tumors over all
target phases.
improvement in Dice and HD is observed with increased COPD severity. Patients #2, #3
and #5 showed highest improvements in Dice coefficient, whereas Patients #1 and #4 did
not benefit tangibly (<5% increase in Dice and <10% decrease in HD) from incorporating
COPD-induced heterogeneity in mechanical properties. Even though Patient #2 has a
higher COPD severity compared to Patient #3 (emphysema and SAD combined), the %
increase in Dice is lower for Patient #2. This is particularly attributed to the sensitivity of
Dice coefficient to the size of the compared volumes.

Table 2-2 The extent of COPD phenotypes represented in their percentage volume
(%V), and the percentage improvement in measures of tumor motion/deformation
estimation for each case.
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The larger the tumor size, the less sensitive the Dice is to variations in the compared
volumes. Patient #2’s tumor size is considerably larger than the Patient #3’s (4.2 cm 3 vs
61.9 cm3), and therefore the %increase in Dice smaller. The % decrease in HD is largest
for Patient #2 with the highest COPD severity (emphysema and SAD combined), and is
smallest for Patients #1 and #4 for with lowest COPD-affected %V.
The accuracy of the tumor motion estimation during respiration was evaluated by
comparing the displacement of the center of mass (CoM) of tumor in 4DCT scans with
that obtained after registration using the homogeneous and heterogeneous FE models
(Figure 2-6). The magnitude of tumor CoM motion during respiration is plotted
separately for each case. The AP and ML components of tumors’ CoM motion were
relatively small (compared to the SI component) and showed similar results for
homogeneous and heterogeneous models. As shown in Figure 2-6 both homogeneous and
heterogeneous models follow the magnitude of tumor’s CoM displacement, however,
heterogeneous model shows superior performance.
To assess the functionality of the proposed biomechanics-based method for lung image
registration, we calculated landmarks registration error (LRE), as a standard measure of
registration error (23,53) for 3 of the patients. LRE was defined as mean Euclidean
distance between 30-40 pairs of landmarks throughout the lung, identified using
bifurcation points in the source (EE, 50%) and the target images. Because manual
landmarks identification is a time-consuming task, we used Patients #2, #3, and #5 as
proof of concept. Table 2-3 shows the LRE before and after registration using the
homogeneous and heterogeneous models for each patient.
Comparing the LRE before and after the registration with either of the homogeneous or
heterogeneous models shows the high accuracy of the biomechanical model-based
registration proposed in this work.
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Figure 2-6. Actual tumor CoM motion magnitude and the simulated tumor CoM motion
magnitude using homogeneous and heterogeneous models.
Table 2-3 Average LRE for all patients before and after registration with homogeneous
and heterogeneous models
Patient #

LREbefore (mm)

2

After Registration
LREHomogeneous(mm)

LREHeterogeneous(mm)

7.67 ± 3.32

2.77 ± 0.93

1.85 ± 0.91

3

6.9 ± 4.28

2.55 ± 1.06

2.23 ± 1.10

5

6.77 ± 4.12

2.51 ± 0.88

1.52 ± 0.90
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2.4

«Discussion»

In this work a patient-specific biomechanical model-based image registration algorithm
was proposed for lung cancer patients that mimics the breathing physiology and
incorporates the pathophysiology of lung in patients with COPD. Specifically, changes in
the structure of lung parenchyma as a result of different COPD phenotypes were
considered in the biomechanical model. The results demonstrated that changes in the
mechanical properties of the lung parenchyma due to COPD have considerable effects on
the accuracy of biomechanics-based image registration algorithm. Particularly, the
heterogeneous FE model resulted in higher accuracies for tumor motion/deformation
estimation compared to its homogeneous counterpart in all patients, regardless of the
variations in size and/or location of the tumor. In addition to the increase in average
accuracy, the error bars are considerably smaller when the heterogeneous model is used
for registration (Figure 2-5). Our method registers the CT image acquired at the EE phase
to other phases of respiration by deforming the EE geometry. As one would expect, the
lowest registration accuracies are observed when the required deformation is the largest,
which is when the target phase for registration is the furthest respiration phase from EE
(the source phase), i.e. the peak-inhale phases. Therefore, the reductions observed in the
error bars along with the increase in the average of the accuracy measures when the
heterogeneous model is used implies increased accuracy of the model, especially for
estimation of large deformation. Considering that lungs undergo large deformation during
respiration, this observation highlights the impact of using optimized hyperelastic
mechanical properties for healthy and pathological tissue sub-types in the FE model.
The estimation of tumor displacement using either of the models closely followed the
actual magnitude of tumor’s CoM displacement, and its components in all directions.
This characteristic of the model is very important in the radiation therapy application
because the model is capable of estimating the location of the tumor during all phases of
respiration, as well as its shape. This is essential for developing intrafracture and
interfracture tumor motion compensation systems.
The proposed image registration technique can also be used for lung image registration in
addition to tumor motion prediction. The proposed lung image registration shows similar

71

accuracy (as represented by LRE) to the current intensity-based DIR algorithms (54,55)
and biomechanics-based image registration methods proposed elsewhere (53). For
example, Han L. et al. proposed a hybrid DIR for lung peak CT pairs that combines a
biomechanical of the lungs with a BSpline-based DIR (56). They showed that the
resulting motion field describes the underlying physiology more realistically, and the
accuracy of registration is improved compared to the intensity-based DIR algorithm (56).
They reported an average target registration accuracy of 1.37 ± 0.89 mm for registering
peak-inspiration CT pairs with 2.5 mm slice thickness and in-plane resolutions ranging
from 0.97 mm × 0.97 mm to 1.16 mm × 1.16 mm.
Respiration motion-induced artifacts cause inaccuracies in current thoracic image
registration methods (57). The quality of the low-dose clinical CT scans including the RT
treatment planning CTs are commonly limited by these artifacts. In this work, the
physiology-inspired biomechanical model performance is not affected by the motion
artifacts present in the dataset, suggesting the capability of the model to be used to
process clinical CT data.
The optimization algorithm maximizes the registration accuracy by finding the proper
mechanical properties of the emphysematous and SAD-affected tissue, located based on
the CT intensity values (HU). This method can potentially be used to provide in-vivo
estimates of tissue mechanical properties of different regions of the lung characterized by
different CT intensities. The estimated mechanical properties possibly provide
supplementary information for tissue characterization in diagnostic and prognostic
applications.
One limitation of the current study is that in all investigated cases, the tumor is in the
right lung. Modeling the motion of the tumors located in the left lung can be more
challenging due to complexities caused by the interactions with the heart mechanics. Our
group has developed and investigated a number of FE models for the heart (58,59).
Future research directions may include integrating the heart and the lung FE models to
obtain realistic biomechanics-based image registration for the left lung.
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Chapter 3

3

« 4DCT Ventilation Imaging Using Biomechanical
Model-based Deformable Registration »

3.1 « Introduction »
Assessment of the lungs regional function represented by either or a combination of
perfusion, diffusion, and ventilation has proven useful in many applications including
lung cancer radiation therapy (1) and diagnosis of pulmonary abnormalities such as
asthma and chronic obstructive pulmonary disease (COPD) phenotypes (2). Current
radiation therapy treatment planning methods assume a homogeneous distribution of lung
function and hence a homogeneous treatment response characterized by radiation dose
distribution. However, many lung cancer patients have co-existing pulmonary
dysfunctions that give rise to pulmonary function heterogeneity (3,4). Functional
avoidance treatment planning that preferentially spares the functional lung tissue from
radiation dose, has been tested in clinical trials, and has shown to 1) help reduce the
incidence and the severity of radiation-induced lung injuries (e.g. radiation pneumonitis
and pulmonary fibrosis) (5–8), and 2) enable target dose escalation for more effective
treatments (9,10). In addition, monitoring changes in the lungs’ regional function during
the course of radiation therapy can be used for evaluating treatment response (11).
Regional function information has also shown to be useful in applications other than
radiation oncology. For example information pertaining to regional distribution and
severity of pulmonary diseases such as asthma and COPD phenotypes can be used to
develop new therapies and improve existing therapeutic methods (12–14).
Information on regional variations of the lung function can be found non-invasively by
various imaging methods. Functional images can be directly generated using positron
emission tomography (PET) (15) and single photon emission computed tomography
(SPECT) (16). Hyperpolarized 3He magnetic resonance (MR) imaging has been used for
imaging ventilation (2,17),

129

Xe MR imaging can be used to obtain information on

ventilation, perfusion, or gas exchange (18), and Xenon-enhanced computed tomography
(CT) can provide a direct assessment of pulmonary ventilation(19). Four dimensional CT
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(4DCT)-based ventilation imaging (CTVI) has recently emerged as a cost-effective and
accessible alternative to the abovementioned modalities, with potentially higher spatial
resolution compared to nuclear medicine ventilation imaging. CTVI is especially
attractive in radiation therapy applications because it can be achieved using treatment
planning 4DCT images acquired as part of the routine care in most centers (20). Clinical
trials on CTVI-based functional avoidance planning are on-going, with the goal of
reducing radiation toxicities (10,21). CTVI has also been used to improve the prediction
of radiation pneumonitis and clinical toxicity. For example, Vinogradskiy et al. found a
potential reduction in radiation induced toxicities (grade 2+ and 3+ pneumonitis) when
CTVI-based functional avoidance planning was used instead of conventional anatomical
planning (8). Moreover, dose-response assessment studies have been conducted by
evaluating changes in the lung ventilation (as mapped by CTVI) between radiation
therapy fractions (22,23) and after radiation therapy (11,24–26).
Different methods have been proposed for CTVI, most of which consist of a “deformable
image registration (DIR)” between the peak respiration CT pairs, and a “ventilation
metric” (27,28). The accuracy of the DIR method used is a major determining factor in
the CTVI accuracy, and hence its clinical benefits (29). Almost all previously proposed
CTVI methods are founded on intensity-based DIR algorithms (27,28). Despite advances
made in DIR methods, they are based solely on 4DCT image data, and are sensitive to
motion artifacts that are frequently encountered in treatment planning 4DCT scans (30).
There exist a few commercial DIR methods including Velocity (Varian Medical Systems,
Palo Alto, CA, USA) and RayStation (RaySearch Laboratories, Stockholm, Sweden),
some open DIR software packages such as Plastimatch (see www.plastimatch.org, last
accessed on August. 2019) and Elastix (see http://elastix.isi.uu.nl/, last accessed on
August 2019), and different in-house methods developed by research labs (27). Intensitybased DIR algorithms do not take into account the physical properties or physiological
mechanisms involved in breathing, hence are prone to errors associated with nonuniqueness of the resulting displacement field and registration errors in areas with low
image gradients. In addition, handling the sliding motion of the lungs can be challenging
for motion estimation using intensity-based DIR methods (31,32).
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Biomechanical models have been widely used alone or in combination with intensitybased methods as alternative to DIR approaches (33,34). In contrast to intensity-based
DIR, biomechanics-based computational models encompass certain physiological aspects
of breathing dynamics rendering this approach more robust and realistic (35–38). Patientspecific lung biomechanical models that use the thoracic image data to extract the lung’s
geometry and boundary conditions have been previously proposed (34,39,40). Several
studies investigated the effects of model parameters including the mechanical properties
(39,41,42), and boundary conditions (38) on modeling accuracy. Recently, hybrid
hierarchical approaches have been proposed, in which finite element (FE)-based
biomechanical models are used in conjunction with intensity-based DIR methods to
predict deformation fields of the lung in a respiratory cycle, and to register lung CT
image pairs (43,44). For example, Han L. et al. proposed a hybrid biomechanical modelbased DIR for lung peak CT pairs, and showed that the resulting motion field describes
the underlying physiology more realistically while the accuracy of registration was
improved compared to the intensity-based DIR algorithm (43). In this study, we are
proposing an accurate biomechanics-based DIR algorithm in conjunction with a
sophisticated lung air segmentation algorithm for CTVI. To our knowledge, we are the
first group to utilize biomechanical models in a CTVI application.
With respect to a ventilation metric, the current CTVI methods are generally classified as
either Hounsfield unit-based (DIR-HU) or Jacobian-based (DIR-Jac) methods, with a few
studies reporting a combination of the two (27). The DIR-HU methods use changes in
voxels intensity between the end-inhale and end-exhale breathing phases to calculate
ventilation. The assumption for calculating ventilation based on DIR-HU is that the lung
CT voxels intensity (CT numbers) comprise a linear combination of the CT number of
water and that of air, both assumed to be constant (0 HU and -1000 HU, respectively) and
therefore the fraction of air within each voxel can be described by a simple linear
function (45). Uncertainties resulting from image noise, beam hardening, scanner
calibration, and acquisition and reconstruction artifact, can render the assumption of
constant CT numbers for tissue and air unreliable (46,47). Using a fixed linear
relationship for all patients may lead to inaccurate estimation of the air volume, and
hence the ventilation. Therefore, we are proposing the incorporation of an accurate air
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volume calculation method that finds patient’s scan-specific values for air and tissue
intensities based on an advanced thresholding algorithm (48,49).
In addition, the DIR-HU methods do not take into consideration the respiratory changes
in the lung volume. On the other hand, the DIR-Jac methods calculate ventilation based
on the determinant of Jacobian of the transformation obtained from DIR of the lung CT at
the end-inhalation phase to the end-exhalation phase image (50). This approach assumes
that local partial derivatives of the deformation field are related to the volume changes of
the corresponding voxel. It does not consider changes in the voxels’ intensity that can be
indicative of changes in the fractional air volume. A CTVI that accounts for both changes
in voxels’ intensity and regional expansion can provide more realistic information on
ventilation.
We are proposing a CTVI technique that combines an accurate biomechanical modelbased DIR, with an advanced patient-specific air volume estimation algorithm. In this
CTVI technique, we also correct for regional volume expansion based on information
obtained from the lung biomechanical model. We evaluate the clinical utility of the
proposed CTVI technique by qualitatively and quantitatively comparing the ventilation
images with hyperpolarizd 3He MRI of the same patients, used in a clinical trial for
functional avoidance planning (3).

3.2

« Materials and Methods »

An overview of the proposed CTVI algorithm is shown in Figure 3-1. Treatment planning
4DCT scans of three patients (see Section 3.2.1.1 for details on data acquisition) are used
in this CTVI study. Using a lung biomechanical model, we deformably register the endexhale (EE) lung CT image to the end-inhale (EI) image. The biomechanical modelbased DIR involves reconstruction of the deformed EE image. After the registration step,
each voxel in the EI image corresponds to a voxel in the deformed EE image. These two
images are fed into an air segmentation algorithm where the distribution of air within
each image is found using an advanced thresholding method that incorporates the partial
volume effect. The air distribution in the deformed EE image is then corrected with
respect to the regional volume expansion information, obtained from the volume change
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Figure 3-1. The proposed CTVI workflow. The peak-inspiration CT scans are registered
using the biomechanics-based DIR. The air segmentation algorithm finds the partial
volume of air in each scan after registration. The regional volume expansion is corrected
for before the CTVI is calculated as the difference between air volumes in end-inhale and
end-exhale voxels.
of corresponding finite elements calculated using finite-element (FE) analysis. The CTVI
is then calculated as the difference between the amount of air in the EI voxels and the
corrected amount of air in the corresponding EE voxels. In the following sections, each of
the abovementioned steps are described in detail.

3.2.1

Data Acquisition

This research was performed in accordance with the institutional research ethics board
approval. Three patients from the FLAIR trial were included in this study (3). Patients
were diagnosed with non-small-cell lung cancer. Treatment planning 4DCT image
sequences, 3He and 1H MR, and 3DCT scans of the patients were used in this study.

3.2.1.1

Treatment Planning 4DCT

A 16-slice Philips Brilliance Big Bore CT scanner (Philips Medical Systems) operating in
helical mode was used with scan parameters: 120kVp and 400mAs/slice for tube
potential and current, respectively. The intra-slice pixel size of the data varied from 0.98
mm × 0.98 mm to 1.11 mm × 1.11 mm among patients, and the slice thickness was 3
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mm for all scans. The 4DCT images were sorted into 10 respiratory phases using the
Real-time Position ManagementTM system.

3.2.1.2

MR Image Data Acquisition

MR imaging was performed using a whole body 3.0 T MR750 system (GE Health Care,
Milwaukee, WI) using a gradient amplitude of 1.94 G/cm and a single channel, rigid
elliptical transmit/receive chest coil (Rapid Biomedical GmbH, Wuerzburg, Germany).
3

He gas was prepared using a polarizer system (HeliSpin, Polarean, Durham, NC, USA)

where polarization levels of approximately 40% were achieved. Hyperpolarized 3He was
diluted with medical-grade N2 gas. Subjects were instructed to inhale the 3He/N2 gas from
functional residual capacity (FRC), from a 1L Tedlar® bag (Jensen Inert Products, FL,
USA), and images were acquired during a 16-second breath hold. Coronal (anatomical)
1

H MRI was performed using the whole-body radiofrequency coil and 1H fast-spoiled,

gradient-recalled echo sequence using a partial echo (16 s total data acquisition,
repetition time [TR] =4.7 ms, echo time [TE] =1.2 ms, flip angle =30°, field of view =40
cm, bandwidth =24.4 kHz, matrix =128 × 80, 15-17 slices, 15 mm slice thickness). 3He
MRI static ventilation images were acquired using a fast gradient echo method using a
partial echo (14 s total data acquisition, TR/TE/flip angle =4.3 ms/1.4 ms/7°, field of
view =40 cm, bandwidth =48.8 kHz, matrix =128 × 80, 15- 17 slices, 15 mm slice
thickness). More details on MRI acquisition are provided in (3).

3.2.1.3

3DCT Scan

Thoracic multi-detector CT images were acquired with the same breath-hold volume and
maneuver used for MRI. Patients were scanned in the supine position during inspiration
breath-hold from FRC after inhaling 1L of N2 gas, using a multi-detector, 64-slice
Lightspeed VCT scanner (General Electric Health Care, Milwaukee, WI) (64 mm × 0.625
mm collimation, 120 kVp, 100 effective mA, tube rotation time = 500 ms, pitch = 1.0). A
spiral acquisition was used and images were reconstructed using a standard convolution
kernel to 1.25 mm slice thickness (3).
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3.2.2

Biomechanical Model-based DIR

The first step of the proposed CTVI is the deformable registration of the peak-respiration
CT image pairs. We developed a patient-specific biomechanical model of the lung to
simulate the lung motion and deformation. Reconstruction of the moving image was
carried out using an FE-based algorithm that finds the deformation field on voxel-level
based on nodal displacements of the FE model.

3.2.2.1

Patient-specific Biomechanical Model of the Lung

A biomechanical model was developed for each patient using data of their 4DCT image
sequence. In the following, major components of the biomechanical model are described.
The geometry of the lung at the relaxed state, i.e. at the EE phase, was used to generate
the reference geometry. For this purpose, an automated segmentation algorithm was
developed based on a Fast-Marching algorithm. The segmentation was validated using
the radiation treatment planning contours provided by the radiation oncologist. The lung
FE meshes with 8-node hexahedral elements (Figure 3-2) were generated using the IAFEMesh software package (Musculoskeletal Imaging, Modeling, and EXperimentation:
MIMX, the University of Iowa, Iowa city, IA, USA) from the 3D lung model obtained
from segmentation at the EE phase.
The lung expansion from the reference geometry (at EE) to EI is attributed to 1) a drop in
the transpulmonary pressure (originally caused by an expansion in the chest cavity), and
2) the diaphragm contraction. Accordingly, to simulate the lung motion/deformation
during respiration in a physiologically-realistic manner, we model these two mechanisms.
To model the transpulmonary pressure, we are applying a negative pressure gradient on
the surface of the mesh, with its amplitude described by:
𝑃(𝑦) = 𝑃1 + 𝑃2 × 𝑦,

(1)

where 𝑦 is the normalized anterior-posterior (AP) location of each surface element’s
center of mass (0 ≤ 𝑦 ≤ 1). The parameters 𝑃2 and 𝑃1 are the linear gradient’s slope and
the minimum pressure at the posterior-most location on the lung surface, respectively.
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(a-1)

(a-2)

(b-1)

(c-1)

(b-2)

(c-2)

Figure 3-2. Models geometry. The top row figures (a-1, b-1, and c-1) show the lung
finite element meshes for the three patients at the end-exhale phase. The bottom row
figures (a-2, b-2, and c-2) show the deformed geometries of the same cases after FE
analysis. The mesh elements are color-coded according to the magnitude of
displacements in mm.
The assumption of having increasing pressure amplitude in the anterior direction is made
to simulate patient’s breathing condition in supine position when the CT is acquired.
Because accurate values for 𝑃1 and 𝑃2 are unknown for each patient (unless measured
invasively), they are found through an inverse-problem formulation which aims at
maximizing the modelling accuracy (the inverse problem is explained at the end of this
section). To model the effect of the diaphragm contraction on the expansion of the lung,
we extracted the deformation of the diaphragm-lung interface using a free-form
deformable image registration algorithm. The displacement field at the diaphragm-lung
interface is then applied to the bottom surface of the FE mesh as prescribed displacement
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boundary conditions (BCs) to model the lung expansion caused by the diaphragm
activity. The quality of the treatment planning 4DCT is usually impaired by motion
artifacts, especially around the diaphragm surface. To make sure our model is robust to
changes in the image quality, we used our previously described method to correct for the
underestimated diaphragm displacement field caused by motion artifacts (explained in
Chapter 2). Briefly, a correction factor, 𝜅𝐶𝐹 (𝑦), was multiplied by the superior-inferior
component of the displacement vectors obtained from free-form registration. 𝜅𝐶𝐹 (𝑦)
depends on the AP coordinate (𝑦) of the node where the displacement is applied, and it
increases quadratically in the posterior direction. The minimum value of 𝜅𝐶𝐹 is 1, and its
maximum value is optimized using the inverse-problem formulation described later in
this section.
The degree of freedom of the lung motion is limited in some surface areas (e.g. near the
apex and in some areas of lung-ribs interfaces). We use a semi-automatic segmentation
algorithm that extracts such surface areas that have very limited motion and constrain
their degrees of freedom from the 4DCT image information for each patient (for more
information, see Section 2.2.2.2). Fixed BCs were applied to the FE nodal points of those
areas.
As for the mechanical properties, taking into account the large deformation of the lungs
during respiration and based on the results published in previous studies on lung
parenchyma mechanical testing and material properties modeling (42,51,52), the lung
tissue was modeled as hyperelastic, described by Yeoh strain energy density function
(53). Where applicable, we segmented the tumor from the CT image at the EE phase, and
identified the location of the tumor in the lung mesh. We modeled the tumor as linear
elastic material.
To estimate the patient-specific parameters of the lung biomechanical model that are not
directly measured, i.e. the parameters defining the pressure (𝑃1 and 𝑃2 ) and 𝜅𝐶𝐹 , an
inverse-problem formulation was developed. This optimization step aims at maximizing
the normalized mutual information (NMI) between the deformed image after the FE
analysis and the target image (segmented lung at the EI phase), as well as minimizing the
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distance between the simulated and actual lung surfaces. The same lung segmentation
algorithm used for EE CT image was employed to segment the lung from the CT image
at the EI phase. Details on the cost function, the initial values, and the convergence
criteria are provided in Section 2.2.3. The optimized parameters are used to obtain the
final displacement field for the FE mesh nodes. The optimization framework was
developed in MATLAB (MathWorks, USA), and ABAQUS/Standard 6.14 (Dassault
Systèmes Simulia Corp., Providence, RI, USA) was used as the FE solver.

3.2.2.2

Image Reconstruction

To calculate NMI during optimization and to reconstruct the deformed moving image
(deformed EE image) after final FE analysis, we need to calculate the deformation field
at the voxel-level from the displacement field defined at the FE mesh nodes. There exist
interpolation techniques such as spline-based methods (thin plate spline, cubic spline,
etc.) that can interpolate values at any point (voxels) from known function values at the
control points (FE nodal points) (54–56). However, these methods can generate
unrealistic and/or unphysical displacement fields (57). As an alternative approach, we
utilized the FE shape functions defined for 8-node hexahedral elements to find the
displacement of any voxel inside a given element from the displacements at the nodes of
the element. The shape functions are defined as Lagrange interpolation in the element’s
natural coordinates. This implies that to find the displacement of each voxel within an
element from the nodal displacements, the location of the voxel in the corresponding isoparametric representation of the encompassing element is required. Although the
transformation from the iso-parametric representation to the physical coordinates is
known, the inverse mapping that is required to find the voxel’s natural coordinates is not
trivial. We used a novel method designed and implemented by our group that finds the
mapping from physical space to iso-parametric (natural) coordinates through an inverseproblem formulation.

3.2.2.3

Evaluation of the Biomechanical Model-based DIR

The high accuracy of the biomechanical model for lung and tumor motion/deformation
estimation was previously reported in Chapter 2 (see Section 2.3). To further evaluate the
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performance of the proposed biomechanical model-based DIR algorithm for the patients
included in this study, we identified approximately 40 landmark pairs at the bifurcation
points on the EE and EI images. These landmarks were used to calculate the landmarks
registration error (LRE). We also measured the Hausdorff surface-to-surface distance
between the reconstructed and target lung surfaces.
We compared the performance of our biomechanics-based registration with intensitybased DIR. We used an off-the-shelf free form deformable registration algorithm to
register the EE scan to the EI scan.

3.2.3

Air Segmentation Algorithm

In the proposed CTVI algorithm, the ventilation metric is defined as the change in the air
volume at each voxel between EI and EE. After the registration step where the
correspondence between the voxels in the EE and EI images is found, the amount of air
in each voxel at both phases is required. For this purpose, we used a slightly modified
version of an advanced thresholding algorithm previously developed in our lab (48). The
accuracy of the air volume estimation is highly dependent on the values denoting air and
tissue intensities. Therefore, instead of using fixed values of -1000 HU and 0 HU for air
and tissue intensities, this algorithm finds patient-specific values to reduce the
uncertainties associated with variable CT scanner parameters or image artifacts. Firstly,
two threshold values are initialized based on the combined histogram of EI and EE lung
images (Figure 3-3) and are used to classify the voxels in the segmented lung images into
3 groups: 1) entirely air voxels, 2) voxels containing air and soft tissue, and 3) entirely
tissue voxels (Figure 3-3(a)). The threshold values were then optimized based on mass
conservation law and soft tissue (e.g. alveoli wall tissue) incompressibility assumption.
More details on the threshold initialization and optimization can be found in (48). The air
volume in voxels in class #1 is the same as the voxel volume and is zero in class #3
voxels. For voxels in the class #2, the partial volume of air (𝑃𝑉𝐴) in each voxel is
calculated as:
𝑃𝑉𝐴 =

𝐼𝑡𝑖𝑠 − 𝐼𝑣𝑜𝑥
,
𝐼𝑡𝑖𝑠 − 𝐼𝑎𝑖𝑟

(2)
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(a)

(b)

Figure 3-3. Finding initial thresholds for air segmentation. (a) The combined histogram
of end-inhale and end-exhale histograms. The two initial thresholds divide the histogram
to 3 regions, air only voxels, air combined with tissue voxels, and tissue only voxels. (b)
The initial thresholds are found as points where the end-inhale and end-exhale
histograms cross.
where 𝐼𝑎𝑖𝑟 and 𝐼𝑡𝑖𝑠 are the average intensity of the voxels in class #1 and #3, respectively.
Multiplying 𝑃𝑉𝐴 with the voxel volume yields the air volume inside the voxel.
We generate the air distribution maps for the segmented lung image at the EI phase, and
the deformed EE image after registration using the air segmentation algorithm (Figure
3-1). The high accuracy of the air segmentation algorithm has been demonstrated using
both in-vivo and ex-vivo studies (48).

3.2.4

Correcting for Regional Volume Expansion

The air ventilation in the lungs is driven by two mechanisms, the regional volume
expansion and the consequent increase in the amount of air. To obtain a physiologically
relevant surrogate of ventilation using CT images, it is important to include the effect of
both mechanisms. In the proposed CTVI algorithm, for the purpose of registration and to
enable calculation of the change in the air volume, we reconstruct the deformed EE
image with voxels corresponding to that of the EI image. Because the lung volume at the
EI phase is larger, the deformed EE image is expanded to match that of the EI. Therefore,
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to obtain a more accurate estimation of the air volume at the EE phase, the amount of air
found from the deformed EE image at each voxel using the air segmentation algorithm
must be corrected by the ratio by which the volume was regionally expanded to match the
EI image. We obtain the regional expansion ratio from the change in the volume of the
mesh elements after analysis. As described in Section 3.2.2.2, we can locate the voxels
inside the FE mesh by inversely mapping physical coordinates to the iso-parametric
space. When the corresponding mesh element is found for a voxel, the regional expansion
at that voxel is defined by:
𝛼𝑣𝑜𝑥 =

𝑉𝑜𝑙𝐸,𝑑𝑒𝑓
,
𝑉𝑜𝑙𝐸,𝑜𝑟𝑖𝑔

(3)

where the 𝛼𝑣𝑜𝑥 is the volume expansion ratio for the voxel 𝑣𝑜𝑥, 𝑉𝑜𝑙𝐸,𝑑𝑒𝑓 is the volume of
the mesh element 𝐸 after the FE analysis, and the 𝑉𝑜𝑙𝐸,𝑜𝑟𝑖𝑔 is the original volume of the
mesh element 𝐸.

3.2.5

Generating the CTVI

Having the corrected air distribution map at the EE phase, and the corresponding air
distribution map at the EI phase, we can obtain the CTVI from the difference in the air
volume distribution. We also generated refined ventilation maps by lowpass filtering
(Gaussian, 𝜎 = 1) and/or binning (3 × 3 × 3, full binning) the air distribution maps (both
at EI and EE), to rectify the uncertainties caused by the small registration errors.

3.2.6

Comparison of the CTVI with Hyperpolarized Gas MRI

We used the 1H and 3He MR images available in the FLAIR dataset to compare our
proposed CTVI with the MR ventilation. As described in Section 3.2.1, the breathing
maneuver during image acquisition is different for treatment planning 4DCT and 3He
MRI. The MR images were acquired during breath-hold at FRC + 1L, while the 4DCT
scans were acquired at free breathing condition. To reduce the impact of the differences
in the breathing maneuver and hence facilitate the comparison between the CTVI
generated at the EI phase of 4DCT and the MRI, we used the breath-hold 3DCT
(performed at the same volume as the 3He MR) to co-register the CTVI to MR images.
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An off-the-shelf free-form deformable registration was used in Insight Toolkit (ITK;
https://itk.org).
To compare the CTVI with the 3He MRI quantitatively, we considered two categories of
well-ventilated (> 25th percentile) and poorly ventilated (0th – 25th percentile) (58). We
calculated the Dice similarity coefficient between the co-registered 3He MRI and CTVI
for each of the poorly and well-ventilated regions.

3.3
3.3.1
The

« Results »
Biomechanical Model-based DIR Accuracy

accuracy of

the

proposed

biomechanical

model

for

lung

and

tumor

motion/deformation has been previously validated (see Section 2.3). The FE-based
reconstruction algorithm was evaluated by comparing the absolute difference image
between the segmented lung images at EE and EI before, and after registration. The
deformed EE images were reconstructed using the FE-based method described in Section
3.2.2.2. Figure 3-4 illustrates the accuracy of the registration qualitatively, showing the
EE image, EI image, reconstructed EE image, and difference images before and after
registration for an arbitrary axial slice for one of the cases. We qualitatively compared the
difference image after registration using our biomechanical model-based method and an
off-the-shelf intensity-based DIR algorithm. Our biomechanical model-based DIR shows
considerably higher performance.
The deformed EE image was also reconstructed using thin plate spline (TPS) to compare
its performance with that of the FE-based reconstruction. Beside the superior
performance of the FE-based reconstruction over TPS closer to the lung peripheries
where the TPS extrapolation generated unrealistic and non-physical deformation fields,
the results were almost identical elsewhere. This highlights the importance of using the
mechanics-based methods if a more accurate and finer displacement field at the voxellevel from the FE mesh nodal displacements are desired. For quantitative assessment of
the accuracy of the DIR method, LRE was calculated for each subject before and after
registration using ~40 pairs of landmarks identified at bifurcation points (Table 3-1).
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(a)

(b)

(c)

(d)

(e)

(f)

Figure 3-4. An example of the registration. (a) Moving image (EI), (b) target image
(EE), (c) Resampled image (deformed EI image, to match EE), (d) difference image
before registration, (e) difference image after registration using intensity-based DIR, and
(f) the difference image after registration using biomechanical model-based DIR.

Table 3-1 Target registration error between EE and EI scans using ~40 landmarks, before
and after FE-based registration.
Patient #

Before Registration (mm)

After Registration (mm)

1

8.30 ± 4.80

1.97 ± 0.58

2

7.01 ± 4.50

2.35 ± 0.75

3

8.81 ± 5.07

2.44 ± 1.05
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3.3.2

CTVI and Qualitative Comparison with 3He MRI

The proposed CTVI algorithm was used to generate ventilation images for the 3 subjects.
Figure 3-5 shows the 3He MRI overlaid on the proton MR (blue) and the corresponding
CTVI overlaid on CT (heatmap). The coronal slices were chosen arbitrarily. As explained
in Section 3.2.6, the MR scans are co-registered to the 4DCT and the figure shows the
closest CTVI coronal slices to the MR slices after co-registration. The 3He MR images
show the distribution of inhaled 3He gas in the lung and the CTVIs show distribution of
air exchanged from EI to EE (i.e. ventilation). As shown in the Figure 3-5, the 3He MRI
agrees well with the corresponding CTVI slices for all cases, while some discrepancies
exist between them. The extent to which the 3He MR agrees with the CTVI appears to be
(a-1)

(a-2)

(b-1)

(b-2)

(c-1)

(c-2)

(a-3)

(b-3)

(c-3)

(a-4)

(b-4)

(c-4)

(a-5)

(b-5)

(c-5)

(a-6)

(b-6)

(c-6)

Figure 3-5. Comparison of the 3He MR and CTVI, both overlaid on CT. Each row
compares 3 coronal slices of one patient, (a) patient #1, (b) patient #2, and (c) patient #3.
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different for each patient. For example, in patient #1 the agreement between the two
modalities appear to be higher than that in patient #2. In addition, in all patients, the
discrepancies mostly occurred in points closer to the inferior regions closer to the
diaphragm, and in some cases at the top right. The disagreement between hyper polarized
MR and CTVI in these lower regions has been shown to be attributed to differences in the
breathing maneuver exercised when the images are acquired (58). The co-registration
between the MR and 4DCT is conducted using an off-the-shelf intensity-based DIR, and
therefore introduces some uncertainties to the 3He MR-CTVI comparison. The MR4DCT is responsible to reduce the impact of the difference in the breathing maneuver
(a-1)

(a-2)

(a-3)

(b-1)

(b-2)

(b-3)

(c-1)

(c-2)

(c-3)

Figure 3-6. Comparing the breathing maneuver. Rows (a), (b), and (c) correspond to
patients #1, #2, and #3, respectively. The first column shows a slice of the 3DCT, taken
at the same inspiration volume as MR, second column shows the corresponding slice on
4DCT, acquired at tidal volume, and the third column is the absolute difference image of
the two.
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between the two modalities. Figure 3-6 shows the difference image between the 4DCT
and the 3DCT (obtained at the same inspiration volume as MR). We can see some
expansion at the top of the lung while the difference is the most predominant at and close
to the diaphragm. Comparing the difference images of the patients, we can see that
patient #3 shows the highest difference between the 4DCT inspiration volume and 3DCT
(or MR) inspiration volume.

3.3.3

Quantitative Comparison with 3He MRI

The Dice similarity coefficients between the 3He MR and CTVI for each of the well- and
poorly ventilated regions were calculated, as shown in Figure 3-7. Patient #1 shows the
best agreement between the two modalities in both well-ventilated and poorly ventilated
regions, while patient #3 shows the lowest agreement. The lower agreement for patient
#3 compared to the other two cases can be attributed to the highest difference in the
inspiration volumes of 4DCT and 3He MR.

Figure 3-7. The Dice similarity coefficient between 3He MR and CTVI for poorly
ventilated and well-ventilated regions for the three patients.

3.3.4

Discussion and Conclusions

Lung ventilation imaging is of growing interest in the biomedical community for its
potential to improve radiation therapy treatment planning, and hence the effectiveness
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and safety of radiation therapy for lung cancer patients. Due to the widespread use of
4DCT for lung cancer therapy, incorporation of CTVI to radiation therapy treatment
planning has become feasible. In this study, we proposed a novel CTVI technique that
combines an accurate biomechanical model-based DIR with an advanced air
segmentation algorithm. We validated the CTVI images generated using our proposed
technique by comparing them with their hyperpolarized gas distribution map counterparts
obtained using 3He MR imaging, both qualitatively and quantitatively.
Firstly, we demonstrated good spatial agreement between the CTVI and 3He MR by
comparing the images qualitatively. We observed some disagreements between the two,
which can be attributed to the difference in the breathing maneuver that has been shown
to largely impact the generated CTVI (58). In addition, it is noteworthy that 3He MR and
CTVI are representatives of different surrogates of ventilation; 3He MR shows the
distribution of 1L of hyperpolarized gas in the lungs that is inhaled from functional
residual capacity (and held for 15 seconds) while CTVI maps the change in the local
volume of air during tidal breathing. Considering that the 4DCT images and the MR
images were taken approximately a week apart, the discrepancies are not expected to be
related to disease progression.
Unlike the CTVI algorithms that rely on intensity-based DIR, our algorithm was not
sensitive to 4DCT image artifacts that happen near or on the diaphragm surface. This is
because of the robustness of the biomechanical model-based DIR to the 4DCT artifacts,
as explained in 2.3.2.
This study is a proof of concept, performed on a small number of patients. The results of
the study are promising and suggest that a larger scale study is required to further validate
the outcome of this study. Furthermore, comparison of our CTVI algorithm against other
available CTVI methods is an important step for validation. Until recently, there has not
been a common validation tool for different CTVI techniques. Kipritidis et al. (27)
recently published the results of a multi-institutional study for validation of CTVI
methods (VAMPIRE study) using different reference modalities that are clinically
accepted for ventilation imaging. Various CTVI methods from seven research groups
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were included in this study, most of which used intensity-based DIR for registration of
peak-respiration CT scans. The ventilation metrics included DIR-Jac, DIR-HU, and two
hybrid ones.

The results of this study demonstrated that the extent of agreement

(represented by measures of correlation or overlap) between different ventilation imaging
modalities are not only dependent on the CTVI technique used, but also highly on the
reference modality and the imaging subject (27). In this study, a biomechanics-based DIR
that used the maximum principle stress as the ventilation metric showed highest
correlation with nuclear medicine modalities (Galligas PET and DTPA-SPECT). The
Dice similarity coefficients were reported as: median Dicelow = 0.52, range Dicelow =
0.36-0.67, for low ventilation regions, and median Dicehigh = 0.45, range Dicehigh = 0.280.62 (27). Although these values cannot be directly compared to the results of our study
(different reference modality, different subjects and sample size, etc.), they demonstrate
that the accuracy of our CTVI algorithm is similar to some of the best current CTVI
algorithms and encourages future studies using our proposed CTVI technique. Finally,
these findings highlight the promise of biomechanical models in DIR applications and
their importance in advancing CTVI methods.

«References»
1.

Ireland RH, Tahir BA, Wild JM, Lee CE, Hatton MQ. Functional Image-guided
Radiotherapy Planning for Normal Lung Avoidance. Clin Oncol [Internet]. 2016
Nov

[cited

2019

Jun

7];28(11):695–707.

Available

from:

https://linkinghub.elsevier.com/retrieve/pii/S0936655516302369
2.

Fain SB, Korosec FR, Holmes JH, O’halloran R, Sorkness RL, Grist TM.
Functional Lung Imaging Using Hyperpolarized Gas MRI. J Magn Reson Imaging
[Internet]. 2007 [cited 2019 Jun 6];25:910–23. Available from: www.interscience.

3.

Hoover DA, Capaldi DPI, Sheikh K, Palma DA, Rodrigues GB, Dar AR, et al.
Functional lung avoidance for individualized radiotherapy (FLAIR): Study
protocol for a randomized, double-blind clinical trial. BMC Cancer. 2014;

4.

Marks LB, Spencer DP, Sherouse GW, Bentel G, Clough R, Vann K, et al. The

99

role of three dimensional functional lung imaging in radiation treatment planning:
The functional dose-volume histogram. Int J Radiat Oncol [Internet]. 1995 Aug
[cited

2019

Jun

7];33(1):65–75.

Available

from:

https://linkinghub.elsevier.com/retrieve/pii/036030169500091C
5.

Yamamoto T, Kabus S, Bal M, Keall P, Benedict S, Daly M. The first patient
treatment

of

computed

tomography ventilation

functional

image-guided

radiotherapy for lung cancer. Radiother Oncol. 2016;
6.

Yamamoto T, Kabus S, Von Berg J, Lorenz C, Keall PJ. Impact of fourdimensional

computed

tomography

pulmonary

ventilation

imaging-based

functional avoidance for lung cancer radiotherapy. Int J Radiat Oncol Biol Phys.
2011;
7.

Faught AM, Miyasaka Y, Kadoya N, Castillo R, Castillo E, Vinogradskiy Y, et al.
Evaluating the Toxicity Reduction With Computed Tomographic Ventilation
Functional Avoidance Radiation Therapy. Int J Radiat Oncol Biol Phys. 2017;

8.

Vinogradskiy Y, Castillo R, Castillo E, Tucker SL, Liao Z, Guerrero T, et al. Use
of 4-dimensional computed tomography-based ventilation imaging to correlate
lung dose and function with clinical outcomes. Int J Radiat Oncol Biol Phys. 2013;

9.

Huang Q, Jabbour SK, Xiao Z, Yue N, Wang X, Cao H, et al. Dosimetric
feasibility of 4DCT-ventilation imaging guided proton therapy for locally
advanced non-small-cell lung cancer. Radiat Oncol [Internet]. 2018 Dec 25 [cited
2019

Jun

7];13(1):78.

Available

from:

https://ro-

journal.biomedcentral.com/articles/10.1186/s13014-018-1018-x
10.

Bradley J, Graham M V., Winter K, Purdy JA, Komaki R, Roa WH, et al. Toxicity
and outcome results of RTOG 9311: A phase I-II dose-escalation study using
three-dimensional conformal radiotherapy in patients with inoperable non-smallcell lung carcinoma. Int J Radiat Oncol Biol Phys. 2005;

11.

Ding K, Bayouth JE, Buatti JM, Christensen GE, Reinhardt JM. 4DCT-based

100

measurement of changes in pulmonary function following a course of radiation
therapy. Med Phys [Internet]. 2010 Feb 24 [cited 2019 Jun 7];37(3):1261–72.
Available from: http://doi.wiley.com/10.1118/1.3312210
12.

Fain S, Schiebler ML, McCormack DG, Parraga G. Imaging of lung function using
hyperpolarized helium-3 magnetic resonance imaging: Review of current and
emerging translational methods and applications. Journal of Magnetic Resonance
Imaging. 2010.

13.

Kaireit TF, Gutberlet M, Voskrebenzev A, Freise J, Welte T, Hohlfeld JM, et al.
Comparison of quantitative regional ventilation-weighted fourier decomposition
MRI with dynamic fluorinated gas washout MRI and lung function testing in
COPD patients. J Magn Reson Imaging [Internet]. 2018 Jun 1 [cited 2019 Jun
7];47(6):1534–41. Available from: http://doi.wiley.com/10.1002/jmri.25902

14.

Kirby M, Svenningsen S, Kanhere N, Owrangi A, Wheatley A, Coxson HO, et al.
Pulmonary ventilation visualized using hyperpolarized helium-3 and xenon-129
magnetic resonance imaging: differences in COPD and relationship to emphysema.
J Appl Physiol. 2013;

15.

Harris RS, Schuster DP. Visualizing lung function with positron emission
tomography. J Appl Physiol. 2007;

16.

Petersson J, Sánchez-Crespo A, Larsson SA, Mure M. Physiological imaging of
the lung: single-photon-emission computed tomography (SPECT). J Appl Physiol.
2007;

17.

Van Beek EJR, Wild JM, Kauczor HU, Schreiber W, Mugler JP, De Lange EE.
Functional MRI of the lung using hyperpolarized 3-helium gas. Journal of
Magnetic Resonance Imaging. 2004.

18.

Mugler JP, Altes TA. Hyperpolarized 129Xe MRI of the human lung. Journal of
Magnetic Resonance Imaging. 2013.

19.

Ding K, Cao K, Fuld MK, Du K, Christensen GE, Hoffman EA, et al. Comparison

101

of image registration based measures of regional lung ventilation from dynamic
spiral CT with Xe-CT. 2012 Jul 27 [cited 2019 Jun 6];39(8). Available from:
http://dx.doi.org/10.1118/1.4736808]
20.

Simpson DR, Lawson JD, Nath SK, Rose BS, Mundt AJ, Mell LK. Utilization of
Advanced Imaging Technologies for Target Delineation in Radiation Oncology. J
Am Coll Radiol. 2009;

21.

Socinski MA, Morris DE, Halle JS, Moore DT, Hensing TA, Limentani SA, et al.
Induction and concurrent chemotherapy with high-dose thoracic conformal
radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: A
dose-escalation phase I trial. J Clin Oncol. 2004;

22.

Vinogradskiy Y, Castillo R, Castillo E, Chandler A, Martel M, Guerrero T. TU‐A‐
BRC‐11: Use of Weekly 4DCT‐Based Ventilation Maps to Quantify Changes in
Lung Function for Patients Undergoing Radiation Therapy. In: Medical Physics.
2011.

23.

Vinogradskiy Y, Faught A, Castillo R, Castillo E, Guerrero T, Miften M, et al.
Using 4DCT-ventilation to characterize lung function changes for pediatric
patients getting thoracic radiotherapy. J Appl Clin Med Phys [Internet]. 2018 Sep 1
[cited

2019

Jun

7];19(5):407–12.

Available

from:

http://doi.wiley.com/10.1002/acm2.12397
24.

Patton TJ, Gerard SE, Shao W, Christensen GE, Reinhardt JM, Bayouth JE.
Quantifying ventilation change due to radiation therapy using 4DCT Jacobian
calculations. Med Phys [Internet]. 2018 Oct [cited 2019 Jun 7];45(10):4483–92.
Available from: https://doi.org/10.1002/mp.13105]

25.

Yamamoto T, Kabus S, Bal M, Bzdusek K, Keall PJ, Wright C, et al. Changes in
Regional Ventilation During Treatment and Dosimetric Advantages of CT
Ventilation Image Guided Radiation Therapy for Locally Advanced Lung Cancer.
Int J Radiat Oncol Biol Phys. 2018;

102

26.

Kipritidis J, Hugo G, Weiss E, Williamson J, Keall PJ. Measuring interfraction and
intrafraction lung function changes during radiation therapy using fourdimensional cone beam CT ventilation imaging. Med Phys. 2015;

27.

Kipritidis J, Tahir BA, Cazoulat G, Hofman MS, Siva S, Callahan J, et al. The
VAMPIRE challenge: A multi-institutional validation study of CT ventilation
imaging. Med Phys [Internet]. 2019 Mar 1 [cited 2019 Jun 26];46(3):1198–217.
Available from: http://doi.wiley.com/10.1002/mp.13346

28.

Hegi-Johnson F, de Ruysscher D, Keall P, Hendriks L, Vinogradskiy Y,
Yamamoto T, et al. Imaging of regional ventilation: Is CT ventilation imaging the
answer? A systematic review of the validation data. Radiother Oncol [Internet].
2019

Aug

1

[cited

2019

Jun

12];137:175–85.

Available

from:

https://www.sciencedirect.com/science/article/pii/S0167814019301148?via%3Dih
ub
29.

Yamamoto T, Kabus S, Klinder T, von Berg J, Lorenz C, Loo BW, et al. Fourdimensional computed tomography pulmonary ventilation images vary with
deformable image registration algorithms and metrics. Med Phys [Internet]. 2011
Feb

16

[cited

2019

Jun

7];38(3):1348–58.

Available

from:

http://doi.wiley.com/10.1118/1.3547719
30.

Yamamoto T, Langner U, Loo BW, Shen J, Keall PJ. Retrospective Analysis of
Artifacts in Four-Dimensional CT Images of 50 Abdominal and Thoracic
Radiotherapy Patients. Int J Radiat Oncol Biol Phys. 2008;

31.

Vandemeulebroucke J, Bernard O, Rit S, Kybic J, Clarysse P, Sarrut D. Automated
segmentation of a motion mask to preserve sliding motion in deformable
registration of thoracic CT. Med Phys. 2012;

32.

Rietzel E, Chen GTY. Deformable registration of 4D computed tomography data.
Med Phys. 2006;

33.

Han L, Dong H, McClelland JR, Han L, Hawkes DJ, Barratt DC. A hybrid patient-

103

specific biomechanical model based image registration method for the motion
estimation of lungs. Med Image Anal [Internet]. 2017 Jul 1 [cited 2019 Jun
18];39:87–100.

Available

from:

https://www.sciencedirect.com/science/article/pii/S1361841517300555
34.

Fuerst B, Mansi T, Carnis F, Sälzle M, Zhang J, Declerck J, et al. Patient-specific
biomechanical model for the prediction of lung motion from 4-D CT images. IEEE
Trans Med Imaging. 2015;

35.

Han L, Dong H, McClelland JR, Han L, Hawkes DJ, Barratt DC. A hybrid patientspecific biomechanical model based image registration method for the motion
estimation of lungs. Med Image Anal. 2017;

36.

Werner R, Ehrhardt J, Schmidt R, Handels H. Patient-specific finite element
modeling of respiratory lung motion using 4D CT image data. Med Phys. 2009;

37.

Fuerst B, Mansi T, Zhang J, Khurd P, Declerck J, Boettger T, et al. A personalized
biomechanical model for respiratory motion prediction. Med Image Comput
Comput Assist Interv. 2012;

38.

Al-Mayah A, Moseley J, Velec M, Brock KK. Sliding characteristic and material
compressibility of human lung: Parametric study and verification. Med Phys.
2009;

39.

Al-Mayah A, Moseley J, Velec M, Hunter S, Brock K. Deformable image
registration of heterogeneous human lung incorporating the bronchial tree. Med
Phys. 2010;

40.

Al-Mayah A, Moseley J, Velec M, Brock K. Toward efficient biomechanicalbased deformable image registration of lungs for image-guided radiotherapy. Phys
Med Biol. 2011;

41.

Al-Mayah A, Moseley J, Velec M, Brock K. Effect of friction and material
compressibility on deformable modeling of human lung. In: Lecture Notes in
Computer Science (including subseries Lecture Notes in Artificial Intelligence and

104

Lecture Notes in Bioinformatics). 2008.
42.

Shirzadi Z, Sadeghi-Naini A, Samani A. Toward in vivo lung’s tissue
incompressibility characterization for tumor motion modeling in radiation therapy.
Med Phys. 2013;40(5):051902.

43.

Han L, Dong H, McClelland JR, Han L, Hawkes DJ, Barratt DC. A hybrid patientspecific biomechanical model based image registration method for the motion
estimation of lungs. Med Image Anal. 2017;

44.

Samavati N, Velec M, Brock K. A hybrid biomechanical intensity based
deformable image registration of lung 4DCT. Phys Med Biol. 2015;

45.

Simon BA. Non-invasive imaging of regional lung function using X-ray computed
tomography. Journal of Clinical Monitoring and Computing. 2000.

46.

Choi S, Hoffman EA, Wenzel SE, Castro M, Lin C-L. Improved CT-based
estimate of pulmonary gas trapping accounting for scanner and lung-volume
variations in a multicenter asthmatic study. J Appl Physiol [Internet]. 2014 Sep 15
[cited

2019

Jun

6];117(6):593–603.

Available

from:

http://www.ncbi.nlm.nih.gov/pubmed/25103972
47.

Castillo R, Castillo E, Martinez J, Guerrero T. TU‐B‐204B‐04: Ventilation from
Four Dimensional Computed Tomography: Density versus Jacobian Methods. In:
Medical Physics. 2010.

48.

Moghadas-Dastjerdi H, Ahmadzadeh M, Samani A. Towards computer based lung
disease diagnosis using accurate lung air segmentation of CT images in exhalation
and inhalation phases. Expert Syst Appl. 2017;

49.

Naini AS, Lee TY, Patel R V., Samani A. Estimation of lung’s air volume and its
variations throughout respiratory CT image sequences. IEEE Trans Biomed Eng.
2011;

50.

Reinhardt JM, Ding K, Cao K, Christensen GE, Hoffman EA, Bodas S V.

105

Registration-based estimates of local lung tissue expansion compared to xenon CT
measures of specific ventilation. Med Image Anal. 2008;12(6):752–63.
51.

Sadeghi Naini A, Patel R V., Samani A. Measurement of lung hyperelastic
properties using inverse finite element approach. IEEE Trans Biomed Eng. 2011;

52.

Zeng YJ, Yager D, Fung YC. Measurement of the Mechanical Properties of the
Human Lung Tissue. J Biomech Eng. 1987;

53.

Yeoh OH. Some Forms of the Strain Energy Function for Rubber. Rubber Chem
Technol. 1993;

54.

Kvasov BI. Cubic Spline Interpolation. In: Methods of Shape-Preserving Spline
Approximation. 2010.

55.

Thévenaz P, Blu T, Unser M. Interpolation revisited. IEEE Trans Med Imaging.
2000;

56.

Bookstein FL. Principal Warps: Thin-Plate Splines and the Decomposition of
Deformations. IEEE Trans Pattern Anal Mach Intell. 1989;

57.

Schreibmann E, Pantalone P, Waller A, Fox T. A measure to evaluate deformable
registration fields in clinical settings. J Appl Clin Med Phys. 2012;

58.

Tahir BA, Marshall H, Hughes PJC, Brightling CE, Collier G, Ireland RH, et al.
Comparison of CT ventilation imaging and hyperpolarised gas MRI: effects of
breathing manoeuvre. Phys Med Biol [Internet]. 2019 Mar 7 [cited 2019 Jun
7];64(5):055013.

Available

from:

http://stacks.iop.org/0031-

9155/64/i=5/a=055013?key=crossref.c8bdad7ad8bb5ff8426576808c53baf5

106

Chapter 4

4

« Conclusion and Future Work »

In this thesis, we described the development of an accurate lung biomechanical model
and its applications towards improving radiation therapy for lung cancer treatment. Two
major applications of the model are tackled, including tumor motion/deformation
compensation and CT based ventilation imaging. These applications were presented in
Chapters 2 and 3 of this thesis. A summary and concluding remarks for each chapter are
given below as closure.

4.1

Chapter 2

In Chapter 2, we described the development of a heterogeneous lung biomechanical
model for motion and deformation estimation of the lung and the tumor. The accuracy of
the proposed lung biomechanical model for tumor tracking was validated using measures
of similarity and distance. In this study, we investigated the effect of incorporating the
heterogeneities in the lung mechanics caused by COPD phenotypes on the tumor motion
and deformation estimation accuracy. While the lung tissue homogeneity assumption for
lung mechanics demonstrated fairly good performance for cases with less COPD severity,
the heterogeneous tissue modeling alternative proved necessary to achieve high tumor
motion/deformation estimation accuracies for cases that suffered from moderate to severe
COPD. Another factor that influenced the accuracy gain achieved through utilizing the
heterogeneous lung model is the proximity of pathological tissue to the tumor. The closer
the pathological tissue to the tumor the higher the impact of utilizing the heterogeneous
lung model. The results of the heterogeneous model for all cases showed promise of this
biomechanical model for incorporation into radiation therapy applications, including but
not limited to the biomechanics-based real time tumor tracking workflow designed by our
group and explained in Section 1.3.5.
The impact of incorporating COPD-induced heterogeneity on tumor motion and
deformation accuracy was shown to be dependent on the extent and distribution of COPD
phenotypes. Considering the higher computation time and cost of developing a

107

heterogeneous model compared to a homogeneous one for a patient, this observation
encourages a study that aims at predicting whether a patient is likely to benefit from a
heterogenous tissue model, or a homogeneous tissue model would provide sufficiently
high accuracy, based on pertinent information from 4DCT.
We acknowledge a number of limitations of this study. The number of patients included
in this study was small. A larger scale study has to be carried out to further validate the
observations of this study and more importantly to enable statistical analysis on the
results (e.g. whether or not the improvement resulting from incorporating the tissue
heterogeneous mechanical properties are statistically significant). To incorporate this
model into a biomechanics-based real time tracking system, the FE analysis needs to be
accelerated. This can be achieved through parallel processing using GPU architecture or
by employing reduced FE model strategies to speed up the computation model
processing. The training of a predictive model that facilitates tumor tracking using the
information from chest surface motion data requires representation of the loading and
boundary conditions in a compact form as explained in (1).

4.2

Chapter 3

In Chapter 3, we described the application of the heterogeneous lung biomechanical
model in combination with an advanced air segmentation algorithm in generating 4DCTbased ventilation maps. Since 4DCT has become part of the standard of care for lung
cancer treatment in many centers, the proposed ventilation imaging algorithm has
potential clinical applications for treatment planning. The potential higher resolution of
CTVI compared to other ventilation imaging modalities can have clinical impacts for
patients who are scheduled for intensity modulated radiation therapies and/or radiation
therapy with ablative doses (SBRT) (2). The accuracy of the 4DCT ventilation maps were
evaluated by comparison with 3He MR scans taken from the same patients. Results of
qualitative and quantitative comparison of the 3He MR with our proposed CTVI
technique are promising and warrant further investigation into improving its performance
before carrying out a larger scale study.
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We hereby acknowledge a number of the study limitations. Firstly, the small number of
patients limits the statistical power of the study. A larger scale study that includes
patients with different cancer stages, tumor locations/sizes, and comorbidity severities is
required to further validate the findings of this study. In addition, SPECT is one of the
reference modalities that is widely used for ventilation and it is important to compare our
proposed CTVI and the acquired 3He MR against the SPECT scans of the same patients
(3–8). The choice of the CTVI algorithm has also been shown to impact the results of
comparison with the reference modalities (9–12). Therefore, different CTVI algorithms
should be used and compared against each other and the reference modalities (such as He
MR or SPECT) to determine which CTVI method offers better physiological
correspondence with SPECT or He MR scans.
Ventilation is only one surrogate for lung function. In functional avoidance planning
applications, it is important to also consider other representations of lung function,
including perfusion and diffusion (4,13–18). Ventilation to perfusion ratio in particular is
an important representation of lung function that can be used to improve functional
avoidance planning (13,19). Therefore, for functional avoidance therapies it is important
to complement the information obtainable from ventilation imaging (e.g. from CTVI)
with maps of distribution of perfusion and/or diffusion to have a more accurate and
realistic assessment of lung regional function.
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